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Outpatient preoperative assessment clinics, such as the physician-led high-risk clinic
in a large metropolitan public hospital in South Australia, have been established to
assess and manage surgical patients at high risk of morbidity and mortality due to
their medical co-morbidities. To date, the design and implementation of preoper-
ative medical assessment and management has been heterogeneous, with minimal
detail on the actual services provided as part of the intervention. Further, there
have been no published studies evaluating the costs and outcomes of physician-led
preoperative assessment for patients with modifiable medical co-morbidities prior to
elective surgery.
Five distinct projects contributed to the main aims of this research: to evaluate
the preoperative assessment and management services provided by the physician-led
high-risk clinic, and provide recommendations for improvement using an explanatory
sequential mixed methods approach.
This research represents the first comprehensive evaluation of services for the
preoperative assessment and management of high-risk surgical patients. Multiple
regression analyses identified nine potentially modifiable medical co-morbidities to
be associated with increased length of stay and postoperative complications, sup-
porting the rationale that optimisation of poorly controlled medical co-morbidities
prior to surgery could improve postoperative outcomes.
The costs and effects of physician-led preoperative assessment and management
were evaluated using a propensity score-based approach with retrospective and pro-
spective data. It was found that the clinic reduced the frequency of unnecessary
admissions and cancellations but significant uncertainty remained around the effect
of the clinic on length of hospital stay, postoperative complications, hospital costs
and post-discharge mortality. Supplemental data on a prospective cohort of patients
identified preoperative health-related quality of life as a potential unmeasured con-
xi
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founder in the evaluation, with high-risk clinic patients reporting lower mean index
scores.
Semi-structured interviews with surgeons found that the factors influencing their
decision to refer a patient to the high-risk clinic appear to be driven by the aim to
manage the uncertainty and risk to the patient regarding surgery and it was seen as
a strategy for managing difficult and complex cases. Additionally, the integration
of the services provided by the clinic in this study appear to offer additional value
in supporting the surgical decision-making process for the surgical team and patient
beyond the clinical outcomes, such as managing the patient’s expectations regarding
care and assistance after discharge from hospital. Further perspectives from patients
and other medical professionals collaborating with the clinic should be explored and
would provide further insight into the aspects of care that provide additional value.
This evaluation provides a guide to the identification of elective surgical patients
who are likely to benefit most from preoperative physician-led medical optimisation
and provides clarity on the collaborative care provided by the high-risk clinic and
surgical teams in managing complex patients, to inform the assessment of such clinics
in Australia. Such models of care involving the management of high-risk patients are
increasingly likely as the public hospital system is subjected to increasing demands
from an ageing population. This research has demonstrated the need to plan for the
robust evaluation of new health service initiatives, which may be facilitated through
better co-ordinated planning and evaluation across Australian hospitals.
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Advances in medical technology and public health initiatives have increased life
expectancy. However, there are consequences in terms of the health and medical
needs of an ageing population, with more than 80% of Australians aged 65 years
and over having three or more co-morbidities (Australian Institute of Health and
Welfare 2007). The presence of co-morbidities, defined as pre-existing distinct med-
ical conditions in addition to a particular index disease (Feinstein 1970), adds to
the complexity of patient care and demand on health care services and systems
(Barnett et al. 2012, Salive 2013, Cummings et al. 2018). In surgical patients, med-
ical co-morbidities and the duration and invasiveness of surgery affect the rate and
extent of post-surgical recovery, resulting in higher health service costs and poorer
patient outcomes (Imamura and Black 1998, Kuwabara et al. 2008, Liu et al. 2010).
While the duration and invasiveness of surgery is dependent on the procedure re-
quired, there are medical co-morbidities that have the potential to be modified with
preoperative assessment and management.
Outpatient preoperative assessment clinics have been established to assess and
manage these high-risk patients, that is, patients undergoing surgery who are at
high risk of morbidity and mortality due to coexistent diseases and/or severity of
surgery, and optimise their medical conditions prior to surgery (Girbes 2000).
3
4 CHAPTER 1. BACKGROUND
1.1.1 Standard preoperative assessment
Standard preoperative assessment is provided by an anaesthetist and, depending
on the patient’s health status, can occur within a few weeks before surgery in an
outpatient setting or on the day of surgery in an inpatient setting. The assessment
is focused on identifying potential implications for surgery and anaesthesia.
Standard preoperative assessment aims to:
• identify factors that may increase risks associated with surgery
• quantify the risk in order to inform decisions regarding the appropriateness
and timing of surgery
• minimise risk through appropriate short- and long-term strategies for man-
aging medical co-morbidities and their associated medication requirements
(Nierman and Zakrzewski 1999)
Previous studies evaluating the impact of preoperative assessment clinics for
elective surgery patients have reported reduced lengths of stay (Harari et al. 2007,
Pollard et al. 1997, van Klei et al. 2002), fewer cancellations after admission for
surgery (Pollard et al. 1997 1996, van Klei et al. 2002), and increased same-day
admissions (Pollard et al. 1997, van Klei et al. 2002). Most of the clinics reported
in these studies were anaesthetist-led (Parker et al. 2000, Pollard et al. 1997 1996,
Schiff et al. 2010, van Klei et al. 2002) and focused on changing the setting of the
clinic from inpatient to outpatient.
Schiff et al. (2010) conducted a randomised controlled trial of anaesthetist-led
preoperative assessment 1-2 days before surgery in an outpatient clinic compared to
in the ward after admission. The total consultation time was significantly reduced,
resulting in cost savings per patient, but the impact on length of stay and complica-
tions were not reported. Two other studies (Pollard et al. 1997, van Klei et al. 2002)
compared the effects of anaesthetist-led preoperative assessment (in an outpatient
setting) 3-4 weeks before surgery with inpatient assessment 1-2 days before surgery
and reported significant reductions in length of stay, fewer operating room cancel-
lations, and increased same-day admissions for surgery. This suggests that allowing
more time to assess and manage patients prior to their scheduled surgical date may
have a positive effect on outcomes.
Standard preoperative assessment can also be referred to as preoperative anaes-
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thetic assessment, anaesthetic preoperative evaluation or preoperative evaluation.
1.1.2 Alternative preoperative assessment
Consultant physicians, also known as hospitalists or internists, are defined as “phys-
icians whose primary professional focus is the general medical care of hospitalised
patients. Their activities include patient care, teaching, research, and leadership
related to hospital medicine, such as quality improvement, effective care transitions
and the efficient use of resources” (Canadian Society of Hospital Medicine 2015).
Physicians have been proposed as alternative providers of preoperative medical
care and offer additional benefits to the integrated care pathway. Anaesthestists
have a different focus and expertise by providing safe anaesthesia and specific peri-
operative management, which complements the role of the physician. The strengths
of physician-led care are:
• the physician is able to optimise the patient’s pre-existing medical conditions
for short- and long-term health improvement, complementing the skillset of the
anaesthetic team, which provides safe anaesthesia and specific perioperative
management
• the potential anaesthetic and surgical burden for the patient are recognised,
and detailed patient management suggestions can be provided to the operative
team
• the patient’s long-term and perioperative needs can be provided to all relev-
ant medical professionals involved with the patient’s care, both in and out of
hospital (Pham et al. 2014)
Preoperative assessment also has the potential to identify previously undiagnosed
co-morbidities. For example, chronic obstructive pulmonary disease (COPD) can be
masked in a patient with osteoarthritis whose pain limits their physical activity. An
analysis of 200 patients with aortic aneurysms uncovered previously undiagnosed
cardiac, respiratory and renal co-morbidity in 19%, 57% and 29% of patients, re-
spectively (Dawson et al. 2007).
A US-based randomised clinical trial compared outpatient preoperative evalu-
ation (OPE) by an internist or internal medicine resident, 2-3 weeks prior to elective
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surgery (intervention), and preoperative evaluation after admission for elective sur-
gery if necessary (control) (Macpherson and Lofgren 1994). No detail on the criteria
used to identify patients for referral to the OPE were provided, only that eligible
patients had to be over 50 years of age and living within 100 miles of the study
hospital. The only difference between the two arms of the trial was the change in
the setting of the clinic from inpatient (control) to outpatient (intervention). The
type of care provided as part of the preoperative evaluation did not change, which
may explain the significantly shorter preoperative length of stay in the outpatient
arm (1.6 days vs. 2.9 days, p<0.001) and non-significant differences in postoperative
and total length of stay.
However, a significant reduction in the proportion of patients who were admit-
ted and then had surgery cancelled was observed in the intervention group (5.7%
vs. 12.3%, p=0.03), which demonstrates the potential cost-savings in reducing the
frequency of inappropriate admissions.
Preoperative assessment provided by a physician can also be referred to as preop-
erative medical evaluation, preoperative medical consultation or preoperative med-
ical optimisation.
1.1.3 Alternative preoperative assessment in South
Australia
Strategies to address medical co-morbidities in surgical patients, in addition to the
standard preoperative assessment performed by the anaesthetist, are being imple-
mented in the United States (Bader et al. 2009, Macpherson and Lofgren 1994) and
United Kingdom (Harari et al. 2007). However, like Australia, these specialised
clinics are not currently widespread with only a handful of hospitals in each country
providing this type of care.
In South Australia, two large metropolitan public hospitals, the Queen Elizabeth
Hospital (TQEH) and the Royal Adelaide Hospital (RAH), established high-risk
clinics for physician-led preoperative assessment and management in 2006 and 2008,
respectively. Both clinics were established by Dr Catherine Gibb, a consultant
physician specialising in the care of high-risk surgical patients by optimising existing
medical co-morbidities prior to surgery, organising preoperative and postoperative
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plans for managing co-morbidities, and providing a second opinion on whether a
patient is fit for surgery.
This research was conducted at the RAH clinic, where high-risk patients receive
preoperative assessment and management in an outpatient setting (i.e. prior to
hospital admission for surgery). The current model of care involves the referral of
patients who have been identified by either the surgeon or anaesthetist as having
medical co-morbidities that may impact on the outcome of elective surgery, and
present possible targets for preoperative optimisation. This is an ad hoc referral
pathway that may result in missed opportunities to improve patient outcomes, but
also potentially inappropriate referrals, where there is a low likelihood for improve-
ment.
The clinic comprises two part-time physicians, one clinical practice (nurse) con-
sultant and one administration officer. The outpatient clinic is open for four sessions
per week (four hours per session) with an average of 16 new patients and eight re-
view patients each week. New patients referred to the clinic require a 45-minute
consultation and review patients a 15-minute consultation.
Figure 1.1 illustrates the differences in the timing and delivery of a preoperat-
ive medical assessment (physician-led) compared with a preoperative anaesthetic
assessment (anaesthetist-led) from the time a patient is placed on the waiting list
and until discharge from the hospital after surgery. Patient appointments with the
clinic can occur from one week (for urgent cancer surgery) and up to 12 months (for
orthopaedic surgery) prior to a hospital admission for surgery. In comparison, the
anaesthetic service generally sees patients up to four weeks before surgery.
1.2 Targeted co-morbidities
It is recognised that there are a subset of modifiable co-morbidities that may be
targeted in the preoperative phase with a view to optimising control and improving
postoperative effects and outcomes. Observational cohort studies have investigated
the impact of pre-existing co-morbidities on length of hospital stay, complications,
and mortality (Crockett et al. 2000, Kuwabara et al. 2008, Librero et al. 1999, Liu
et al. 2010, Rochon et al. 1996, Roe et al. 1998). A retrospective study on 520
patients admitted to hospital with a primary diagnosis of chronic airflow limita-
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Waiting list Admission Surgery Discharge
Physician-led
Manage and optimise pre-
existing medical co-morbidities
Diagnose new medical 
conditions
Provide continuity of care
Facilitate communication 
between surgeon, anaesthetist 
and GP
Up to 12 months
Anaesthetist-led
Manage any medical/surgical 
issues related to anaesthetic 
during surgery
Assess patient pre- and post-
surgery
Focus is getting the patient 
through surgery
Up to 4 weeks
Figure 1.1: The timing of a preoperative medical assessment (shaded in grey)
compared with a preoperative anaesthetic assessment.
tion reported significantly longer mean lengths of stay in patients with five or more
co-morbidities (Crockett et al. 2000). Other retrospective cohort studies also re-
ported increases in mean lengths of stay and mortality with increasing number of
co-morbidities and complications in patients admitted for a range of hospitalisations
(Kuwabara et al. 2008, Librero et al. 1999, Liu et al. 2010, Rochon et al. 1996, Roe
et al. 1998). Librero et al. (1999) also reported increases in risk of readmission at
30 days and 1 year as the number of co-morbidities increased. However, these stud-
ies only indicate that there is an association between the number of co-morbidities
and postoperative outcomes and readmissions, and none differentiated between co-
morbidities that may or may not have the potential to be optimised prior to elective
surgery.
The high-risk clinics in South Australia target eight selected co-morbidities that
have the potential to be managed and optimised prior to elective surgery. Of the
eight co-morbidities that are targeted by the high-risk clinics in South Australia, five
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are taken from the Revised Cardiac Risk Index (RCRI) (Lee et al. 1999). The RCRI
is a widely used and validated tool designed to predict cardiac-related complications
after mixed non-cardiac surgery. This index comprises six independent predictors:
high-risk type of surgery, ischaemic heart disease, history of congestive heart failure,
history of cerebrovascular disease, insulin therapy for diabetes, and renal impair-
ment. The presence of two or more of these predictors indicates an increased risk
for perioperative cardiac complications. In order to broaden the scope of this in-
dex beyond cardiac-related complications, the high-risk clinic included three other
clinically important predictors: respiratory disorders, anaemia and dementia.
Asthma and COPD, along with age, obesity and smoking have been identified as
risk factors for postoperative pulmonary complications. Risk reduction strategies in
the preoperative assessment clinics have been shown to reduce related mortality and
length of stay (Khan and Hussain 2005). Preoperative anaemia is associated with an
increased likelihood of red blood cell transfusion and increased risk of morbidity and
mortality (National Blood Authority 2012). For elective surgical patients, undia-
gnosed anaemia is common, particularly in the elderly and those with co-morbidities
such as diabetes, congestive heart failure or other inflammatory conditions (Good-
nough et al. 2003). Recent patient blood management guidelines recommend the
evaluation of surgical patients as early as possible to allow management and optim-
isation of haemoglobin and iron stores (National Blood Authority 2012).
Due to the ageing population in developed countries, dementia represents a sig-
nificant challenge to health service delivery. In Australia, dementia was reported in
26.4 per 1,000 women aged over 60 and 20.3 per 1,000 men aged over 60 who were
admitted to hospital in 2003-04 (Australian Institute of Health and Welfare 2006).
With a mean length of hospital stay of 19.6 days for patients with any diagnosis of
dementia (e.g. either as the reason for admission to hospital or as a co-morbidity) in
2003-04, co-morbid dementia has an impact on patient recovery and requires addi-
tional care and management in hospital (Australian Institute of Health and Welfare
2006, Hannan et al. 2001). Guidelines for the management of older persons with
delirium recommend strategies for prevention, detection and treatment (Australian
and New Zealand Society for Geriatric Medicine 2012).
The theoretical and clinical rationale of the high-risk clinic in South Australia is
that the aforementioned co-morbidities, if not already well managed, could present
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as possible targets for preoperative assessment and management and potentially
improve postoperative outcomes.
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The aims of this research were to evaluate the preoperative assessment and manage-
ment services provided by the physician-led high-risk clinic, and provide recommend-
ations for improvement using an explanatory sequential mixed methods approach.
Specifically, four areas were explored:
1. The effects of specific co-morbidities on postoperative outcomes and the po-
tential for such co-morbidities to be optimised prior to surgery (Chapter 3).
2. A review of the existing evidence on the effectiveness of preoperative assess-
ment and management provided by physicians (Chapter 4).
3. The costs and effects of preoperative assessment and management provided
by physicians compared with standard practice in high-risk patients scheduled
for elective surgery (Chapters 5 and 6).
4. The practices of surgeons and how their relationships with the high-risk clinic
influence the management and treatment of complex patients (Chapter 7).
Key co-morbidities
A cohort of patients was sampled based on the presence of eight key co-morbidities
targeted in the high-risk clinic: ischaemic heart disease, congestive heart failure,
stroke, diabetes mellitus, renal impairment, anaemia, asthma or COPD, and de-
mentia (including Alzheimer’s disease).
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Selected surgical procedures
To limit the heterogeneity of primary diagnoses and associated surgical procedures,
the selected cohorts were restricted to: transurethral resection of the prostate, total
joint replacement (hip and knee), abdominal aortic aneurysms, head and neck can-
cer, and colorectal cancer. These are the five most common primary diagnoses in
high-risk clinic patients, and account for approximately two-thirds of all high-risk
clinic referrals.
Key outcomes
The key outcomes for this evaluation were: costs, length of hospital stay, postoper-
ative complications, quality of life, and 12-month mortality.
Significance
To date, there have been no published studies evaluating the costs and outcomes
of physician-led preoperative assessment for patients with modifiable medical co-
morbidities prior to elective surgery. More effective preoperative management of
these patients will have a significant effect on health service costs, the capacity of the
hospital system in particular, and the health service in general. The importance of
these improvements will increase over time as the public hospital system is subjected
to increasing demands from an ageing population.
The development of a systematic and evidence-based process to guide the refer-
ral of elective surgical patients for preoperative physician-led medical optimisation
will enable health care professionals to provide better, more efficient care with the
potential for reduced complications, morbidity, and mortality after surgery.
Five distinct research projects were conducted, and are presented in this thesis as
follows:
Part II covers two projects that focus on the clinical rationale and system-
atic literature review. Chapter 3 presents the data to support the rationale for
targeting specific co-morbidities that have the potential to be managed and op-
timised prior to elective surgery. Multiple regression analyses using retrospective
17
data were conducted to estimate the effect of potentially modifiable co-morbidities
on postoperative outcomes and to identify co-morbidities that could be targeted
for preoperative assessment and management. Chapter 4 provides a full system-
atic review of the existing evidence on the effectiveness of preoperative assessment
and management provided by physicians. This review summarises all the available
evidence, the various models of care provided by physicians, and fills a gap in the
literature.
Part III covers three projects that form the evaluation component. Chapter 5
describes the evaluation, using retrospective data, of the cost and effects of an out-
patient clinic providing physician-led preoperative assessment and management in
Adelaide, South Australia. A supplementary prospective study was also conducted
to explore quality of life, as measured by the EQ-5D, as a potentially unmeasured
confounding factor in the evaluation. Additional detail and discussion on the meth-
odological challenges with analysing a complex patient population are also provided
in this chapter. Chapter 6 details the additional follow-up data collected as an
extension of the supplementary prospective study in Chapter 5 to explore the po-
tential effects of the high-risk clinic on quality of life. Chapter 7 describes the
explanatory study undertaken to assess the validity of findings from the retrospect-
ive evaluation. Figure 2.1 provides a visual representation of the explanatory se-
quential mixed methods approach for this evaluation component. The visual model
illustrates the sequence of research activities and specifies the data collection and
analysis procedures for each stage.
Part IV concludes this thesis by summarising the main findings and providing re-
commendations for future research.
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DATA COLLECTION DATA ANALYSIS 
QUANTITATIVE 
Retrospective Data 
 Selected surgical procedures 
 Routinely collected data (patient 
characteristics, clinical outcomes, 
hospital separation costs) 
 Propensity score weighting and 
matching of clinic and control 
patients 
 Comparison of outcomes 
  Interpretation and explanation of 
the quantitative and qualitative 
findings 
 Validation of variables and 





 Selected surgical procedures 
 Routinely collected data (patient 
characteristics, clinical outcomes) 
 Patient-reported quality of life 
data before and after surgery 
 Propensity score weighting and 
matching of clinic and control 
patients 
 Comparison of outcomes 
 Determined whether quality of life 




 Selected surgeons who were 
eligible to refer patients to the 
clinic 
 Developed interview questions on 
reasons for referral and 




QUALITATIVE Phases  
 Individual face-to-face interviews 
 Audio-recorded for transcription 
 Coding and thematic analysis 
 Explored how high risk patients 
are managed with and without the 
involvement of the clinic 
 Identified additional factors that 




Figure 2.1: Visual model of the explanatory sequential mixed methods approach








This chapter presents an analysis of a retrospective dataset to support the theoretical
and clinical rationale of the high-risk clinic, with findings published in the Australian
and New Zealand Journal of Surgery. The article identifies a set of co-morbidities
that can potentially be modified within the preoperative period, and should be
targeted for physician-led medical optimisation based on their estimated impact on
length of stay, postoperative complications and in-hospital mortality.
The set of potentially modifiable co-morbidities include ischaemic heart disease,
congestive heart failure, stroke, diabetes mellitus, renal impairment, anaemia, de-
mentia including Alzheimer’s disease, and asthma or chronic obstructive pulmonary
disease, which are currently targeted by the high-risk clinic physicians.
Findings from this analysis also identified an additional potentially modifiable
co-morbidity, primary hypertension (as opposed to hypertension secondary to other
disorders), which the high-risk clinic physicians now target for medical optimisation.
This is the first study to report the effects of specific co-morbidities on postoperative
outcomes and explores the potential for such co-morbidities to be optimised prior
to surgery.
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Abstract
Background: There are a subset of potentially modifiable co-morbidities that may be
targeted in the preoperative phase with a view to optimizing control and improving
post-operative outcomes. This study aims to estimate the effect of potentially modi-
fiable co-morbidities on post-operative outcomes and to identify potential targets for
preoperative management.
Methods: Retrospective data on hospital separations in South Australia were
analyzed using multiple regression to estimate the association between nine potentially
modifiable co-morbidities and length of stay, post-operative complications and
in-hospital mortality.
Results: After adjusting for primary diagnosis, age, gender and other potential con-
founders, significant increases in length of stay and complications were recorded for
eight and six of the nine modifiable co-morbidities, respectively. As examples, previ-
ous heart failure was associated with a 54% increase in length of stay and an odds ratio
of 1.75 for complications. Asthma and chronic obstructive pulmonary disease was
associated with a 38% increase in length of stay and an odds ratio of 1.64 for
complications.
Conclusions: A set of potentially modifiable co-morbidities is associated with a range
of poorer post-operative outcomes, relative to patients without those co-morbidities.
There is a clinical rationale that outcomes will be worse in the subset of patients for
whom such co-morbidities are poorly controlled, and that timely intervention to
improve control in the period prior to surgery will improve post-operative outcomes.
Further research is required on post-operative outcomes for patients with and without
controlled co-morbidities and on the effects of timely intervention to improve control
prior to surgery.
Introduction
Medical co-morbidities in surgical patients affect the rate and extent
of post-surgical recovery, resulting in higher health service costs and
poorer patient outcomes.1 Observational cohort studies have inves-
tigated the impact of co-morbidities on length of hospital stay, com-
plications and mortality.2–7 A retrospective study on 520 patients
admitted to hospital with a primary diagnosis of chronic airflow
limitation reported significantly longer mean lengths of stay (LoS) in
patients with five or more co-morbidities.2 Other retrospective
cohort studies also reported increases in mean LoS and mortality
with increasing number of co-morbidities and complications in
patients admitted for a range of hospitalizations.3–7
It is recognized that there are a subset of potentially modifiable
medical co-morbidities that may be targeted in the preoperative
phase with a view to optimizing control and improving post-
operative outcomes. However, these studies only indicate that there
is an association between the number of co-morbidities and post-
operative outcomes and readmissions, and none differentiate
between co-morbidities that may and may not have the potential to
be optimized prior to elective surgery. To inform potential improve-
ments with respect to the management of surgical patients, it may be
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more appropriate to examine the post-operative effects of medically
modifiable co-morbidities (i.e. those that have the potential to be
managed and optimized prior to elective surgery).
Strategies to address medical co-morbidities in surgical patients,
in addition to the standard preoperative assessment performed by the
anaesthetist (anaesthesiologist in the United States), are being
implemented in the United States8 and United Kingdom.9 However,
like Australia, these specialized clinics are not widespread with only
a handful of hospitals in each country providing this type of care.
The aim of this study was to estimate the effect of potentially
modifiable co-morbidities on post-operative outcomes and to iden-
tify potential targets for preoperative management. Here, we under-
take statistical modelling of a large administrative dataset to estimate
the burden of potentially modifiable co-morbidities on post-
operative outcomes, review options for intervention to improve
control of the defined co-morbidities and discuss the impact of our
findings for future research in this area.
Methods
Data sources
Retrospective data from the Integrated South Australian Activity
Collection (ISAAC), which contains information on every hospital
separation (public and private) in South Australia, were used for the
analysis. The data extracted for each record had been manually
coded from patients’ medical records using a pro forma common
across all contributing hospitals. Ongoing audits of the coded data
were undertaken to ensure accuracy and consistency. Each record
contained information on patient age, gender, type of residence (e.g.
nursing home), principal diagnoses, additional diagnoses with asso-
ciated time of onset flags (to identify diagnoses that were present on
admission), procedures undertaken, as well as a range of variables
relating to the nature of the separation (e.g. elective, emergency,
transfer from another hospital). Postcode level socio-economic indi-
cators were merged into the ISAAC dataset.
All separations from 1 July 2008 to 30 June 2010 were included
in a master dataset. Patients aged over 18 years, undergoing at least
one elective surgical separation and who were admitted between 1
July 2009 and 30 June 2010, were selected for the main analysis.
This subset provided a minimum 12-month pre-admission period
over which we could identify pre-existing co-morbidities from pre-
vious separations. If multiple eligible separations occurred, the latest
surgical separation was selected as the index event. Patients were
excluded if they did not have surgery, the index event was cardiac or
obstetric related or if the Australian Refined Diagnostic Related
Group (AR-DRG) had a LoS in the 90th percentile of 1, as they were
deemed to be low-risk surgical procedures, such as admissions for
coronary angiography or renal dialysis.
Ethics approval was granted by the South Australian Department
of Health Human Research Ethics Committee (HREC Protocol No.
490/01/2015).
Coding of co-morbidities
The following eight potentially modifiable co-morbidities were
selected as the core set of conditions, based upon the protocols of
existing physician-led preoperative clinics in South Australia:
anaemia, diabetes mellitus, congestive heart failure (CHF), stroke,
renal impairment, ischaemic heart disease (IHD), dementia (includ-
ing Alzheimer’s disease) and respiratory disease (asthma or chronic
obstructive pulmonary disease (COPD)). For each index separation,
binary variables describing the presence or absence of these
co-morbidities were coded. Additional co-morbidities were also
coded (see Supporting Information Appendix S1 for a complete
listing of codes for co-morbidities) to assess the impact of other
potentially modifiable co-morbidities and to include as potential
confounders (non-targeted co-morbidities).
Coding of co-morbidities was informed by recorded International
Classification of Diseases, 10th Revision (ICD-10) principal and
additional diagnostic codes, using an adaptation of the coding
process used to define clinical performance indicators for the Vari-
able Life Adjusted Display (VLAD) system.10 The VLAD coding
process was amended so that the diagnostic codes for the targeted
co-morbidities only included the conditions that were deemed poten-
tially modifiable. For example, as a potentially modifiable
co-morbidity, anaemia only included codes for nutritional anaemias
and not haemolytic or aplastic anaemias. The ICD-10 codes for each
of the targeted co-morbidities are listed in Supporting Information
Appendix S2. Diagnoses listed in separations in the 12 months prior
to the index event, as well as additional diagnoses at the time of the
index surgical event, were used to identify relevant co-morbidities.
Outcome measures
Measures of outcome were LoS, complications and in-hospital mor-
tality. Unadjusted LoS was measured in hours, whereas binary vari-
ables were created to represent the occurrence of post-operative
complications and in-hospital mortality.
To determine the potential differences in LoS for patients with and
without potentially modifiable co-morbidities, expected LoS was
estimated as the mean LoS for patients with no potentially modifi-
able co-morbidities for each 3-character AR-DRG. The 3-character
code was used as the 4-character codes differentiate between
patients with and without co-morbidities and/or complications.
Complications were identified through the onset flag variable.
Patients were identified as having a post-operative complication if
the onset of a condition occurred during the episode of admitted
patient care and was not present on admission. Complications were
also stratified using ICD-10 complication codes by category: gas-
trointestinal, wounds, infections, renal and endocrine, cardiovascu-
lar disorders, pulmonary and neurological disorders, to provide more
detail on the types of complications reported for each co-morbidity.11
The complication codes used for each category are listed in Sup-
porting Information Appendix S3.
Statistical analysis
Descriptive and regression-based analyses were undertaken on each
of the defined measures of post-operative outcome. The descriptive
analyses present the unadjusted mean LoS and relative risk (RR)
ratios (with 95% confidence intervals) for LoS, complications and
in-hospital mortality between patients with different numbers of
potentially modifiable co-morbidities (1 or 2 or more) and patients
926 Pham et al.
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with no potentially modifiable co-morbidities, as well as between
patients with each of the defined potentially modifiable
co-morbidities.
A multiple regression model was fitted using ordinary least
squares regression with log-transformed LoS as the dependent vari-
able.12 As well as binary variables for each potentially modifiable
co-morbidity, other model covariates included age, gender,
AR-DRG group (75 groups fitted as a series of 74 dummy variables)
and non-targeted co-morbidities. Age was fitted as a restricted cubic
spline with four knots to capture non-linearity. This model for LoS
was used to estimate the number of bed-days saved per patient and
across the patient base over the 2 years. One co-morbidity was
eliminated at a time from the model, using 10 000 bootstrapped
samples each time. The same method was used to estimate bed-days
saved for those with at least one potentially modifiable co-morbidity,
assuming that the effects of all potentially modifiable co-morbidities
were eliminated with treatment.
Logistic regression models were fitted to complications and
in-hospital mortality using the same covariates for the LoS regres-
sion. Model fit was assessed using the R2 statistic and residual plots.
Analyses were undertaken using Stata, release 12.0 (StataCorp
LP, College Station, TX, USA) and R statistical software (http://
www.r-project.org, Vienna, Austria). P-values less than 0.05 were
considered statistically significant.
Results
A total of 46 925 elective surgical patients across 75 AR-DRGs were
included in the analysis. Overall mean age was 55.5 ± 16.6 years;
56% were female. Of the 75 AR-DRGs, the main major diagnostic
categories were diseases and disorders of the musculoskeletal
system and connective tissue (27%), digestive system (18%) and
female reproductive system (10%).
In addition to the eight originally specified potentially modifiable
co-morbidities, initial LoS analyses identified primary hypertension
(as opposed to hypertension secondary to other disorders) as another
potentially modifiable co-morbidity. The following results include
primary hypertension as a ninth potentially modifiable co-morbidity.
Three non-targeted co-morbidities (malignancy, circulatory system
disorders (excluding IHD and CHF), and intestinal disorders)
covered the highest proportion of patients and were included in the
regression model as potential confounders.
Sixteen per cent of patients had at least one potentially modifiable
co-morbidity. Table 1 describes the unadjusted RR ratios for the three
outcome measures by number and type of potentially modifiable
co-morbidities and non-targeted co-morbidities. There was a positive
association between age and number of co-morbidities. Compared to
the absence of any potentially modifiable co-morbidities, patients
with one potentially modifiable co-morbidity had a significantly
increased LoS (mean 1.1 days), likelihood of post-operative compli-
cations (RR 1.5) and in-hospital mortality (RR 7.3). These values
increased exponentially for patients with more than one potentially
modifiable co-morbidity (4.2 extra inpatient days, and RRs of 3.3 and
32.1 for complications and in-hospital mortality, respectively).
All of the potentially modifiable co-morbidities were associated
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the minimum difference in LoS between patients with and without
each co-morbidity was over 4 days. All but co-morbid stroke had a
significantly increased RR of complications, although the effect of
renal impairment was marginal. The effect on in-hospital mortality
was larger, with even renal impairment having a mean RR of 3.3.
The three selected non-targeted co-morbidities were all associated
with significantly increased LoS, risk of complications and risk of
in-hospital mortality (Table 1).
With regard to the types of post-operative complications (Table 2),
patients with more than one potentially modifiable co-morbidity had
significantly increased risk for all complication categories, particularly
for renal and endocrine, and neurological complications. For each of the
potentially modifiable co-morbidities, CHF had consistently higher risks
of complications in all categories, IHD had very high risks for cardio-
vascular and neurological complications, and dementia including Alz-
heimer’s disease increased the risks of neurological, wounds and
infection complications (Table 2). The three selected non-targeted
co-morbidities also had increased risk across all complication categories,
with higher risks of gastrointestinal and wound complications for malig-
nancy and intestinal disorders, and neurological complications for circu-
latory system disorders (Table 2).
Table 3 presents the outputs of the multivariate regression models.The
coefficients for each binary co-morbidity parameter can be interpreted as
the ratio of the outcome measure between patients with a co-morbidity
and those without that co-morbidity, but who may have other
co-morbidities. The models with coefficients for each potentially modi-
fiable co-morbidity and additional covariates are listed in Supporting
Information Appendix S4. After adjusting for age, gender, AR-DRG
group and major non-targeted co-morbidities, eight of the nine poten-
tially modifiable co-morbidities had a significantly increased LoS. The
difference in LoS was greatest between patients with and without demen-
tia, CHF and asthma/COPD. Patients with dementia are likely to require
77% more bed-days than patients without dementia, and those with CHF
require 54% more bed-days than those without. By comparison, patients
with hypertension or anaemia require only 26% more bed-days than
those without these co-morbidities. The ratio for stroke was 0.86,
although there remains significant uncertainty around this result and a
positive effect cannot be ruled out. CHF and asthma/COPD had the
greatest effect on the probability of a complication, whereas IHD signifi-
cantly increased the likelihood of having a complication or death in
hospital. Anaemia was not significantly associated with an increased
likelihood of a complication but had a significantly increased likelihood
of death in hospital.
Table 4 shows the number of bed-days that could be saved
per patient and over the patient group if the LoS effects for each
potentially modifiable co-morbidity could be removed. For individual
co-morbidities, the saving could be up to 2.6 days per patient. Across
all patients with at least one potentially modifiable co-morbidity, the
estimated saving is over 6000 bed-days over the 2-year period.Across
all patients with at least one potentially modifiable co-morbidity, the
Table 2 Unadjusted relative risk (95% confidence interval) of complication categories by co-morbidity
Gastrointestinal Wounds Infections Renal and endocrine Cardiovascular Pulmonary Neurological
Number of potentially modifiable co-morbidities†
0 Reference Reference Reference Reference Reference Reference Reference
1 1.67 1.38 1.56 2.14 1.69 1.45 1.73
(1.44–1.93) (1.11–1.72) (1.42–1.72) (1.87–2.45) (1.52–1.88) (1.23–1.71) (1.16–2.58)
2+ 3.23 2.96 2.26 3.93 2.95 2.43 4.34
(2.75–3.81) (2.28–3.84) (2.02–2.51) (3.37–4.58) (2.62–3.32) (2.03–2.92) (2.87–6.55)
Type of potentially modifiable co-morbidities‡
Ischaemic heart disease 2.22 2.81 1.69 1.92 3.25 2.30 4.39
(1.63–3.00) (1.80–4.39) (1.40–2.04) (1.45–2.54) (2.80–3.78) (1.75–3.04) (2.52–7.58)
Congestive heart failure 2.96 4.95 2.05 3.48 3.20 2.85 3.63
(1.94–4.52) (2.77–8.79) (1.61–2.62) (2.67–4.53) (2.49–4.12) (1.92–4.21) (1.19–10.92)
Stroke 2.17 2.30 1.45 1.31 1.02 — —
(0.74–6.37) (0.38–13.98) (0.63–3.33) (0.28–6.15) (0.21–4.90)
Diabetes mellitus 2.56 2.13 1.80 2.43 2.00 2.20 1.97
(2.18–3.00) (1.59–2.83) (1.62–2.00) (2.10–2.82) (1.76–2.27) (1.85–2.60) (1.15–3.32)
Renal impairment 1.23 1.06 1.26 1.71 1.11 0.89 1.13
(1.06–1.44) (0.82–1.35) (1.15–1.38) (1.52–1.91) (0.98–1.25) (0.70–1.12) (0.72–1.74)
Anaemia 2.51 2.39 1.88 2.27 2.12 1.47 2.23
(2.11–2.97) (1.79–3.19) (1.68–2.09) (1.93–2.66) (1.86–2.41) (1.12–1.91) (1.30–3.74)
Dementia incl. Alzheimer’s 2.12 3.32 2.01 2.14 2.13 1.00 7.93
(1.30–3.45) (1.77–6.17) (1.62–2.49) (1.48–3.09) (1.55–2.93) (0.34–2.90) (4.45–14.00)
Asthma/COPD 1.46 1.85 1.62 1.98 1.60 3.15 1.71
(0.98–2.17) (1.09–3.12) (1.35–1.94) (1.54–2.53) (1.24–2.06) (2.59–3.84) (0.63–4.53)
Primary hypertension 2.62 2.40 1.78 2.74 2.61 1.99 3.49
(2.28–3.02) (1.90–3.02) (1.61–1.96) (2.40–3.11) (2.37–2.88) (1.68–2.34) (2.47–4.85)
Selected non-targeted co-morbidities
Malignancy 2.24 2.09 1.83 1.62 1.43 1.77 1.65
(2.06–2.44) (1.84–2.36) (1.72–1.95) (1.48–1.78) (1.32–1.54) (1.60–1.96) (1.26–2.13)
Circulatory system disorders§ 1.59 1.67 1.35 1.64 1.76 1.54 2.41
(1.39–1.82) (1.37–2.03) (1.23–1.48) (1.45–1.85) (1.61–1.93) (1.33–1.78) (1.79–3.18)
Intestinal disorders 1.86 1.96 1.50 1.63 1.42 1.70 1.13
(1.59–2.17) (1.54–2.47) (1.36–1.67) (1.40–1.89) (1.24–1.63) (1.43–2.01) (0.60–2.06)
†Relative risks are relative to reference group (i.e. relative to having no potentially modifiable co-morbidities); ‡Relative risks are relative to patients without the
specified co-morbidity. §Excluding ischaemic heart disease and congestive heart failure. COPD, chronic obstructive pulmonary disease.
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number needed to optimize (to remove the effects of the
co-morbidities) to save an additional bed day was 1.23.
Discussion
To date, no published studies have reported the specific effects of
potentially modifiable co-morbidities on post-operative length of
hospital stay and outcomes. The findings from this analysis suggest
that a set of potentially modifiable co-morbidities are associated
with poorer post-operative outcomes, relative to patients without
those co-morbidities. This supports the theory that certain
co-morbidities, if not already well managed, could present as pos-
sible targets for optimization prior to surgery and potentially
improve some post-operative outcomes.
The Revised Cardiac Risk Index13 is a widely used validated tool
designed to predict cardiac-related complications after mixed
non-cardiac surgery. Six independent predictors comprise this
index: high-risk type of surgery, IHD, history of CHF, history of
cerebrovascular disease, insulin therapy for diabetes and renal
impairment. The presence of two or more of these predictors indi-
cates an increased risk for perioperative cardiac complications. To
expand beyond cardiac-related complications, other clinically
important predictors should be included. Findings from this analysis
support the inclusion of additional risk factors, such as age, respira-
tory disorders, anaemia and dementia.
Asthma and COPD have been identified as risk factors for post-
operative pulmonary complications, and risk reduction strategies in
preoperative assessment clinics have been shown to reduce related
mortality and LoS.14 Preoperative anaemia is associated with an
increased likelihood of red blood cell transfusion and increased
risk of morbidity and mortality.15 For elective surgical patients,
undiagnosed anaemia is common, particularly in the elderly and
those with co-morbidities such as diabetes, CHF or inflammatory
conditions.16 Recent patient blood management guidelines recom-
mend the evaluation of surgical patients as early as possible to
allow management and optimization of haemoglobin and iron
stores.15
Due to the ageing population in developed countries, dementia
represents a significant challenge to health service delivery. With a
mean LoS in 2003–2004 of 19.6 days for patients with any diagnosis
of dementia (e.g. either as the reason for admission to hospital or as
a co-morbidity), co-morbid dementia has an impact on patient recov-
ery and requires additional care and management in hospital.17,18
Guidelines for the management of older persons with delirium rec-
ommend strategies for prevention, detection and treatment.19 Table 5
summarizes the range of strategies used by the physician-led clinics
in South Australia for the medical management of patients with
potentially modifiable co-morbidities.
The strengths of physician-led care, as a complement to standard
anaesthetist-led care, include:
• The physician’s skillset in optimizing the patient’s pre-existing
medical conditions for short- and long-term health improve-
ment is, in this setting, complementary to the skillset of the
anaesthetic team who provide safe anaesthesia and specific
perioperative management.
• The recognition of the potential anaesthetic and surgical burden
for the patient, and provision of detailed patient management
suggestions to the operative team.
• Ensuring communication about the patient’s long-term and
perioperative needs to all relevant medical professionals
involved with the patient’s care, both in and out of hospital.
Preoperative assessment also has the potential to identify previ-
ously undiagnosed co-morbidities, for example, COPD can be
masked by the presence of surgical co-morbidities (e.g. a person
who cannot exercise to the point of symptoms because of limitation
by pain from osteoarthritis). An analysis of 200 patients with aortic
aneurysms uncovered previously undiagnosed cardiac (19%), res-
piratory (57%) and renal co-morbidities (29%).27
Table 3 Adjusted estimates comparing those with and without the co-morbidity for length of stay, complications and in-hospital mortality
Potentially modifiable co-morbidity LoS (ratio†) Complications (OR‡) In-hospital mortality (OR‡)
Ischaemic heart disease 1.16 (1.06–1.26) 1.48 (1.14–1.91) 5.50 (2.83–10.67)
Congestive heart failure 1.54 (1.31–1.80) 1.75 (1.11–2.76) 1.95 (0.76–4.99)
Stroke 0.86 (0.64–1.15) 0.35 (0.11–1.05) 1.78 (0.18–17.43)
Diabetes 1.22 (1.16–1.28) 1.35 (1.15–1.59) 2.12 (1.12–3.99)
Renal impairment 1.10 (1.06–1.14) 1.26 (1.11–1.43) 1.50 (0.86–2.64)
Anaemia 1.27 (1.20–1.33) 1.07 (0.92–1.26) 2.86 (1.72–4.76)
Dementia incl. Alzheimer’s 1.77 (1.55–2.01) 1.41 (0.97–2.05) 1.79 (0.61–5.27)
Asthma/COPD 1.38 (1.28–1.49) 1.64 (1.29–2.09) 1.70 (0.68–4.24)
Hypertension 1.26 (1.20–1.32) 1.37 (1.19–1.59) 0.75 (0.40–1.39)
†Ratio of the geometric mean LoS for those with the co-morbidity to the geometric mean LoS for those without. ‡Odds of a complication or death in the group with
the co-morbidity relative to those without. 95% confidence intervals in parentheses. COPD, chronic obstructive pulmonary disease; OR, odds ratio.
Table 4 Bed-days saved by removing the effect of modifiable
co-morbidities, per patient and for whole patient group
Potentially modifiable
co-morbidity
Per patient Whole patient group
Ischaemic heart disease 0.62 (0.56–0.67) 250 (228–274)
Congestive heart failure 2.42 (2.05–2.79) 274 (232–316)
Stroke −0.75 (−1.00–0.56) −24 (−32–18)
Diabetes 0.81 (0.77–0.84) 1112 (1066–1159)
Renal impairment 0.22 (0.21–0.23) 909 (882–936)
Anaemia 1.06 (1.01–1.11) 1248 (1191–1306)
Dementia incl.
Alzheimer’s
2.62 (2.31–2.93) 434 (384–486)
Asthma/COPD 1.11 (1.02–1.20) 548 (504–595)
Hypertension 1.00 (0.97–1.04) 1814 (1750–1877)
≥1 potentially modifiable
co-morbidity
0.81 (0.78–0.84) 6119 (5898–6348)
Numbers reported as mean bed-days saved per patient with 95% confidence
intervals in parentheses; total bed-days saved for the whole patient group
with 95% confidence intervals in parentheses. COPD, chronic obstructive
pulmonary disease.
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Limitations
The prevalence of co-morbidities in the administrative dataset that
informed the reported analysis is likely to be under-estimated as
such data are generated by coders, who can only extract information
that is recorded in patient notes. Under-recording is likely to be more
significant for co-morbidities such as previous stroke, anaemia and
dementia. However, this limitation is likely to result in conservative
estimates of effect due to the misclassification of patients with
potentially modifiable co-morbidities. This limitation may explain
the reported non-significant effect of co-morbid stroke.
Furthermore, the available data were not granular enough to deter-
mine whether the potentially modifiable co-morbidities were well
managed prior to surgery and did not require optimization. Patients
with well-controlled co-morbidities would have limited scope for
improved post-operative outcomes and would therefore not be the
target for preoperative management. Thus, the reported effects of
potentially modifiable co-morbidities are combined effects across
patients with and without optimal control of those co-morbidities. It
is reasonable to assume that outcomes will be worse in patients with
poorly managed co-morbidities, and so the reported effects for this
sub-group are likely to be underestimated.
This underestimate of effect is countered by the likelihood that opti-
mally controlled patients with potentially modifiable co-morbidities may
still experience poorer outcomes than patients without co-morbidities,
and that optimal control may not be achieved prior to surgery for all
patients with co-morbidities (either due to non-compliance of the patient
or the need for surgery sooner rather than later). The scarcity of data
describing the prevalence of surgical patients with inadequately con-
trolled potentially modifiable co-morbidities, combined with the evi-
dence reported in this analysis regarding the general effects of such
co-morbidities, emphasizes the need for further research in this high-
volume area of health service activity.
The current study describes the rationale for preoperative inter-
vention, as well as summarizing the preoperative intervention strat-
egies that may be used to reduce such effects. However, in a resource
constrained health care system, it is necessary to provide evidence
on costs and benefits to support funding decisions for new services.
Moreover, the decision to fund preoperative optimization is not a
single, binary decision to fund or not to fund. There are also deci-
sions around the capacity and scope of the service. Given that the
capacity is likely to be insufficient to cover all surgical patients with
at least one potentially modifiable co-morbidity, there is a need to
determine the prioritization of patients and to develop a systematic
and evidence-based process to guide referral of elective surgical
patients for preoperative physician-led medical optimization.
Conclusions
A set of potentially modifiable co-morbidities is associated with
a range of poorer post-operative outcomes, relative to patients
without those co-morbidities. This finding suggests that certain
co-morbidities, if not already well managed, could present as
possible targets for optimization prior to surgery and potentially
improve post-operative outcomes. Further research is warranted on
the effectiveness and cost-effectiveness of the preoperative manage-
ment of surgical patients with non-optimized potentially modifiable
co-morbidities. The importance of service improvements for high-
risk surgical patients will increase over time as hospital systems are
subjected to increasing demands from an ageing population.
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Table 5 Preoperative interventions for the nine potentially modifiable
co-morbidities
Co-morbidity Preoperative medical intervention
Anaemia Diagnose if previously undetected
Investigate cause of anaemia
Arrange appropriate iron/B12 or folate
supplementation as required
Consider for erythropoietin in associated renal
failure
[Patient Blood Management Guidelines15]
Diabetes mellitus Diagnose severity of diabetes
Screen for suboptimal diabetic control
Suggest post-operative inpatient guideline
management






Diagnose severity of symptoms and
investigate if appropriate
Plan appropriate post-operative fluid
management
Optimize medication for long-term outcome
[Guidelines for the Prevention, Detection and
Management of Chronic Heart Failure in
Australia21]
Stroke Optimize antiplatelet therapy
Optimize use of guideline therapy, e.g. ACE
inhibition
Consider lifestyle intervention if required
[Clinical Guidelines for Stroke Management22]
Renal impairment Diagnose if previously undetected
Plan management of perioperative medication
Consider treatment of associated anaemia
Plan dialysis requirements if dialysis
dependent




Diagnose severity of any ischaemic
symptoms and investigate if appropriate
Optimize medication for prevention of
perioperative ischaemia
[Reducing Risk in Heart Disease24]
Dementia incl.
Alzheimer’s
Determine the presence or extent of any
cognitive impairment
Plan nursing requirements for post-operative
delirium
Implement guidelines for delirium
management




Diagnose if previously undetected
Investigate severity of disease and associated
respiratory failure
Optimize inhaled and oral therapy for
prevention and treatment
Recommend post-op management plans
[COPD-X Guidelines25]
Primary hypertension Diagnose if previously undetected
Optimize medication prior to surgery
[Guide to Management of Hypertension26]
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3.3.1 Online supplementary material
Appendix S1. ICD-10 codes used to identify non-targeted co-morbidities.




I0 Rheumatic fever and heart diseases
I22, I23, I24 Subsequent acute myocardial infarction, certain current com-
plications following acute myocardial infarction, other acute
ischaemic heart diseases
I26-I28 Pulmonary heart disease and diseases of pulmonary circula-
tion
I30-I49, I51, I52 Other forms of heart disease, excluding heart failure
I65-I69 Occlusion and stenosis of precerebral and cerebral arteries
(not resulting in cerebral infarction), other cerebrovascular
diseases and disorders
I7-I9 Diseases of arteries, arterioles and capillaries, diseases of
veins, lymphatic vessels and lymph nodes, unspecified dis-
orders of the circulatory system
Intestinal disorders
K21 Gastro-oesophageal reflux disease
K52 Other non-infective gastroenteritis and colitis
K55-K59 Vascular disorders of intestine, paralytic ileus and intestinal
obstruction without hernia, diverticular disease of intestine,
irritable bowel syndrome, other functional intestinal disorders
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Appendix S2. ICD-10 codes used to identify the nine key modifiable co-
morbidities.
ICD-10 code ICD-10 description
Ischaemic heart disease
I20 Unstable angina
I21 Acute myocardial infarction






I62 Other non-traumatic intracranial haemorrhage
I63 Cerebral infarction
I64 Stroke, not specified as haemorrhage or infarction
Diabetes mellitus
E10 Insulin-dependent diabetes mellitus
E11 Non-insulin-dependent diabetes mellitus
E13 Other specified diabetes mellitus
E14 Unspecified diabetes mellitus
Renal impairment
N0 Glomerular diseases
N1 Renal tubulo-interstitial diseases
N17-N19 Renal failure
N2 Urolithiasis, other disorders of kidney and ureter
N3 Other disease of urinary system
Anaemia
D50-D53 Nutritional anaemias
Continued on next page
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Appendix S2 (continued)
ICD-10 code ICD-10 description
D62 Acute post-haemorrhagic anaemia
D63 Anaemia in chronic diseases classified elsewhere
D64 Other anaemias
Dementia including Alzheimer’s disease
F00 Dementia in Alzheimer’s disease
F01 Vascular dementia
F03 Unspecified dementia
Asthma/chronic obstructive pulmonary disease
J40-J47 Chronic lower respiratory diseases
Hypertension
I10 Essential (primary) hypertension
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Appendix S3. ICD-10 complication codes for stratification by category.
ICD-10 code ICD-10 description
Gastrointestinal
K228 Other specified diseases of oesophagus
K250 Gastric ulcer, acute with haemorrhage
K252 Gastric ulcer, acute with both haemorrhage & perforation
K254 Gastric ulcer, chronic or unspecified with haemorrhage
K256 Gastric ulcer, chronic or unspecified with both haemorrhage
& perforation
K260 Duodenal ulcer, acute with haemorrhage
K261 Duodenal ulcer, acute with perforation
K262 Duodenal ulcer, acute with both haemorrhage & perforation
K264 Duodenal ulcer, chronic or unspecified with haemorrhage
K265 Duodenal ulcer, chronic or unspecified with perforation
K266 Duodenal ulcer, chronic or unspecified with both haemorrhage
& perforation
K270 Peptic ulcer, acute with haemorrhage
K272 Peptic ulcer, acute with both haemorrhage & perforation
K274 Peptic ulcer, chronic or unspecified with haemorrhage
K276 Peptic ulcer, chronic or unspecified with both haemorrhage &
perforation
K280 Gastrojejunal ulcer, acute with haemorrhage
K282 Gastrojejunal ulcer, acute with both haemorrhage & perfora-
tion
K284 Gastrojejunal ulcer, chronic or unspecified with haemorrhage
K286 Gastrojejunal ulcer, chronic or unspecified with both haem-
orrhage & perforation
K290 Acute haemorrhagic gastritis
Continued on next page
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Appendix S3 (continued)
ICD-10 code ICD-10 description
K550 Acute vascular disorders of intestine
K559 Vascular disorder of intestine, unspecified
K560 Paralytic ileus
K565 Intestinal adhesions with obstruction
K566 Other & unspecified intestinal obstruction
K567 Ileus, unspecified
K625 Haemorrhage of anus and rectum
K631 Perforation of intestine (non-traumatic)
K638 Other specified diseases of intestine
K660 Peritoneal adhesions
K650 Acute peritonitis
K720 Acute and subacute hepatic failure
K729 Hepatic failure, unspecified
K85 Acute pancreatitis
K913 Post-operative intestinal obstruction
K914 Colostomy and enterostomy malfunction
K918 Other post-procedural disorders of digestive system, not else-
where classified
K919 Post-procedural disorder digestive system, unspecified
K92 Other diseases of digestive system
T792 Traumatic secondary & recurrent haemorrhage
T810 Haemorrhage & haematoma complicating a procedure, not
elsewhere classified
T888 Other specified complications of surgical & medical care, not
elsewhere classified
Continued on next page
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Appendix S3 (continued)





K632 Fistula of intestine
K829 Disease of gallbladder, unspecified
K832 Perforation of bile duct
L89 Decubitus ulcer and pressure area
N360 Urethral fistula
N824 Other female intestinal-genital tract fistulae
T812 Accidental puncture and laceration during a procedure, not
elsewhere classified
T813 Disruption of operation wound, not elsewhere classified
T815 Foreign body accidentally left in body cavity or operation
wound following a procedure




A49 Bacterial infection of unspecified site
B95 Streptococcus & staphylococcus as the cause of diseases clas-
sified to other chapters
B96 Other specified bacterial agents as the cause of diseases clas-
sified to other chapters
J100 Influenza with pneumonia, other influenza virus identified
J110 Influenza with pneumonia, virus not identified
J12 Viral pneumonia, not elsewhere classified
Continued on next page
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Appendix S3 (continued)
ICD-10 code ICD-10 description
J13 Pneumonia due to Streptococcus pneumoniae
J14 Pneumonia due to Haemophilus influenzae
J15 Bacterial pneumonia, not elsewhere classified
J16 Pneumonia due to other infectious organisms, not elsewhere
classified
J17 Pneumonia in diseases classified elsewhere
J18 Pneumonia organism, unspecified
J690 Pneumonitis due to food and vomit
J85 Abscess of lung and mediastinum
J86 Pyothorax
K61 Abscess of anal and rectal regions




N10 Acute tubulo-interstitial nephritis
N12 Tubulo-interstitial nephritis, not specified as acute or chronic
N151 Renal and peri-nephric abscess
N159 Renal tubulo-interstitial disease, unspecified
N300 Acute cystitis
N309 Cystitis, unspecified
N390 Urinary tract infection, site not specified
R788 Finding of other specified substances, not normally found in
blood
T793 Post-traumatic wound infection, not elsewhere classified
Continued on next page
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ICD-10 code ICD-10 description
T802 Infections following infusion, transfusion and therapeutic in-
jection
T814 Infection following a procedure, not elsewhere classified
T816 Acute reaction to foreign substance accidentally left during a
procedure
T827 Infection & inflammatory reaction due to other cardiac & vas-
cular devices, implants and grafts
T836 Infection & inflammatory reaction due to prosthetic device,
implant and graft in genital tract
T857 Infection & inflammatory reaction due to other internal pros-
thetic devices, implants and grafts
Renal & Endocrine
E15 Non-diabetic hypoglycaemic coma
E272 Addisonian crisis
E86 Volume depletion
E87 Other disorders of fluid, electrolyte & acid-base balance
N139 Obstructive & reflux uropathy, unspecified
N17 Acute kidney failure
N19 Unspecified kidney failure
N312 Flaccid neuropathic bladder, not elsewhere classified
N990 Post-procedural renal failure
N999 Post-procedural disorder of genitourinary system, unspecified
R33 Retention of urine
Cardiovascular
I21 Acute myocardial infarction
I26 Pulmonary embolism
I46 Cardiac arrest
Continued on next page
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Appendix S3 (continued)
ICD-10 code ICD-10 description
I48 Atrial fibrillation and flutter
I49 Other cardiac arrhythmias
I50 Heart failure
I74 Arterial embolism and thrombosis
I80 Phlebitis and thrombophlebitis
I81 Portal vein thrombosis
I82 Other venous embolism and thrombosis
I950 Idiopathic hypotension
I952 Hypotension due to drugs
I959 Hypotension, unspecified
I978 Other post-procedural disorders of circulatory system, not
elsewhere classified
I979 Post-procedural disorder of circulatory system, unspecified
R57 Shock, not elsewhere classified
T790 Air embolism (traumatic)
T800 Air embolism following infusion, transfusion and therapeutic
injection
T801 Vascular complications following infusion, transfusion and
therapeutic injection
T811 Shock during or due to a procedure, not elsewhere classified
T817 Vascular complications following a procedure, not elsewhere
classified
T882 Shock due to anaesthesia
Pulmonary
J80 Adult respiratory distress syndrome
J81 Pulmonary oedema
J90 Pleural effusion, not elsewhere classified
Continued on next page
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Appendix S3 (continued)
ICD-10 code ICD-10 description
J91 Pleural effusion in conditions classified elsewhere
J93 Pneumothorax
J955 Post-procedural subglottic stenosis
J958 Other post-procedural respiratory disorders
J959 Post-procedural respiratory disorder, unspecified
J960 Acute respiratory failure
J969 Respiratory failure, unspecified
J981 Pulmonary collapse
R09 Other symptoms & signs involving the circulatory & respir-
atory systems
Neurological
F05 Delirium, not induced by alcohol & other psychoactive sub-
stances
F13 Mental & behavioural disorders due to use of sedatives or
hypnotics
F15 Mental & behavioural disorders due to use of other stimulants,
including caffeine
F19 Mental & behavioural disorders due to multiple drug use &
use of other psychoactive substances
G45 TIAs (cerebral) & related syndromes
G46 Vascular syndromes of brain in cerebrovascular diseases
G81 Hemiplegia
G82 Paraplegia and tetraplegia
G931 Anoxic brain damage, not elsewhere classified
G936 Cerebral oedema
G970 Cerebrospinal fluid leak from spinal puncture
G971 Other reaction to spinal & lumbar puncture
Continued on next page
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Appendix S3 (continued)
ICD-10 code ICD-10 description
G978 Other post-procedural disorders of nervous system
G979 Post-procedural disorder of nervous system, unspecified
I63 Cerebral infarction
I65 Occlusion & stenosis of pre-cerebral arteries, not resulting in
cerebral infarction
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Appendix S4. Models with coefficients for each modifiable co-morbidity and ad-
ditional covariates for (a) length of stay, (b) complications, and (c) in-hospital mor-
tality.
(a) Length of stay
Ordinary least squares regression
Covariates Coefficient estimate 95% CI P(>| t |)
Age (rcs1) 0.004 0.002, 0.006 0.000
Age (rcs2) 0.001 -0.003, 0.006 0.538
Age (rcs3) 0.017 -0.003, 0.037 0.097
Sex (female) 0.060 0.042, 0.078 0.000
Ischaemic heart disease 0.147 0.063, 0.232 0.000
Congestive heart failure 0.430 0.273, 0.588 0.000
Stroke −0.154 -0.446, 0.137 0.300
Diabetes 0.196 0.144, 0.248 0.000
Renal impairment 0.097 0.061, 0.132 0.000
Anaemia 0.235 0.184, 0.286 0.000
Dementia incl. Alzheimer’s 0.571 0.441, 0.700 0.000
Asthma/COPD 0.321 0.245, 0.397 0.000
Hypertension 0.232 0.184, 0.280 0.000
Malignancy 0.303 0.272, 0.334 0.000
Circulatory system diseases 0.068 0.032, 0.104 0.000
Intestinal disorders 0.061 0.023, 0.098 0.002
CI, confidence interval; COPD, chronic obstructive pulmonary disease; rcs, restricted
cubic spline.
Adjusted R2: 0.525 (DRG dummy variables have been omitted from the table)




Covariates Coefficient estimate 95% CI P(>| z |)
Age (rcs1) 0.005 -0.004, 0.014 0.289
Age (rcs2) 0.006 -0.015, 0.026 0.574
Age (rcs3) 0.026 -0.058, 0.110 0.549
Sex (female) 0.017 -0.052, 0.086 0.631
Ischaemic heart disease 0.391 0.132, 0.645 0.003
Congestive heart failure 0.560 0.101, 1.012 0.016
Stroke −1.060 -2.323, -0.062 0.060
Diabetes 0.299 0.136, 0.460 0.000
Renal impairment 0.230 0.101, 0.359 0.000
Anaemia 0.071 -0.089, 0.229 0.381
Dementia incl. Alzheimer’s 0.342 -0.037, 0.710 0.073
Asthma/COPD 0.494 0.249, 0.733 0.000
Hypertension 0.317 0.172, 0.461 0.000
Malignancy 0.361 0.247, 0.474 0.000
Circulatory system diseases 0.058 -0.073, 0.187 0.385
Intestinal disorders −0.006 -0.136, 0.123 0.930
CI, confidence interval; COPD, chronic obstructive pulmonary disease; rcs, restric-
ted cubic spline.
Nagelkerke’s R2: 0.216 (DRG dummy variables have been omitted from the table)






Covariates Coefficient estimate 95% CI P(>| z |)
Age (rcs1) 0.213 0.051, 0.465 0.043
Age (rcs2) −0.243 -0.537, -0.030 0.059
Age (rcs3) 1.337 0.323, 2.592 0.020
Sex (female) −0.410 -0.854, 0.022 0.066
Ischaemic heart disease 1.704 1.016, 2.347 0.000
Congestive heart failure 0.665 -0.330, 1.563 0.166
Stroke 0.578 -2.450, 2.544 0.619
Diabetes 0.750 0.100, 1.368 0.020
Renal impairment 0.408 -0.170, 0.955 0.153
Anaemia 1.051 0.529, 1.549 0.000
Dementia incl. Alzheimer’s 0.584 -0.613, 1.575 0.289
Asthma / COPD 0.531 -0.472, 1.378 0.255
Hypertension −0.292 -0.932, 0.318 0.360
Malignancy 1.244 0.678, 1.824 0.000
Circulatory system diseases 0.845 0.331, 1.338 0.000
Intestinal disorders 0.034 -0.581, 0.598 0.910
CI, confidence interval; COPD, chronic obstructive pulmonary disease; rcs, restricted
cubic spline.
Nagelkerke’s R2: 0.271 (DRG dummy variables have been omitted from the table)




assessment and management: a
systematic literature review
4.1 Preface
This chapter details the systematic review of the available evidence on preoperat-
ive assessment and management provided by physicians in elective surgery patients,
published in the BMJ Open journal. The reviewers for this manuscript noted that
this was an important area of perioperative practice that currently lacks a previously
published systematic review. With an ageing population, increasing co-morbidities
and an increase in surgical procedures, this article draws attention to the limitations
in previous research and provides recommendations that may stimulate further re-
search in this area.
For the purposes of publication in a US journal, preoperative assessment and
management by consultant physicians has been referred to as preoperative medical
consultation by internal medicine physicians.
This is the first systematic review of the literature evaluating the effects of pre-
operative medical consultation on postoperative outcomes.
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AbstrAct
Objective Clinics have been established to provide 
preoperative medical consultations, and enable the 
anaesthetist and surgeon to deliver the best surgical 
outcome for patients. However, there is uncertainty 
regarding the effect of such clinics on surgical, in-hospital 
and long-term outcomes. A systematic review of the 
literature was conducted to determine the effectiveness of 
preoperative medical consultations by internal medicine 
physicians for patients listed for elective surgery.
Design Systematic searches of MEDLINE, EMBASE, 
CINAHL, PubMed, Current Contents and the NHS Centre 
for Reviews and Dissemination were conducted up to 30 
April 2017.
setting Elective surgery.
study selection Randomised controlled trials and non-
randomised comparative studies conducted in adults.
Outcome measures Length of hospital stay, perioperative 
morbidity and mortality, costs and quality of life.
results The one randomised trial reported that 
preadmission preoperative assessment was more effective 
than the option of an inpatient medical assessment 
in reducing the frequency of unnecessary admissions 
with significantly fewer surgical cancellations following 
admission for surgery. A small reduction in length of stay 
in patients was also observed. The three non-randomised 
studies reported increased lengths of stay, costs and 
postoperative complications in patients who received 
preoperative assessment. The timing and delivery of the 
preoperative medical consultation in the intervention group 
differed across the included studies.
conclusion Further research is required to inform the 
design and implementation of coordinated involvement 
of physicians and surgeons in the provision of care for 
high-risk surgical patients. A standardised approach 
to perioperative decision-making processes should 
be developed with a clear protocol or guideline for the 
assessment and management of surgical patients.
IntrODuctIOn
Preoperative medical consultations are an 
important component in the care of patients 
undergoing elective surgery. Patients who are 
at high risk of morbidity and mortality due to 
pre-existing comorbidities and the severity of 
surgery1 are targeted for preoperative medical 
consultations by internal medicine physi-
cians. Such consultations involve optimising 
pre-existing medical conditions (eg, diabetes 
mellitus, ischaemic heart disease); assessing 
and managing risk of morbidity and mortality; 
initiating interventions intended to decrease 
perioperative risk (eg, delirium manage-
ment, pulmonary preoperative evaluation 
with postoperative recommendations) and 
where appropriate, recommending the defer-
ment or cancellation of surgery. This differs 
to but complements the care provided during 
a preoperative anaesthetic assessment that 
every patient receives prior to surgery.
With increasing patient age and complexity 
of medical conditions, there is a need for 
comprehensive preoperative evaluation and 
medical optimisation to enable the anaesthe-
tist and surgeon to deliver the best surgical 
outcome.2 3 The concept of preoperative 
medical assessment by internal medicine 
physicians is moving beyond the early adopter 
stage, with preoperative physician-led clinics 
being set up across the USA and internation-
ally. In the USA, several dedicated preopera-
tive assessment clinics have been established 
to address this need and provide high-quality 
care.4Centres such as the Internal Medicine 
Perioperative Assessment, Consultation, and 
Treatment Center have been included as part 
of the preoperative evaluation model at the 
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Research
strengths and limitations of this study
 ► The effectiveness of preoperative medical 
consultation is uncertain due to a lack of high-level 
comparative evidence.
 ► The design of services applied to date is 
heterogeneous, but the consolidation of existing 
evidence has identified potential elements of 
preoperative assessment that may contribute to 
better outcomes, such as eligibility criteria for 
referral, and the timing and process of assessment.
 ► Despite the limited evidence base, the presented 
review assembles and critically appraises the 
available evidence and draws some preliminary 
findings that may inform the design and adaptation 
of new and existing preoperative clinics.
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Cleveland Clinic Foundation, with the aim to provide 
thorough, timely and cost-effective assessment of surgical 
patients.3 In Australia, the Royal Adelaide Hospital and 
the Queen Elizabeth Hospital have consultant physi-
cian-led clinics dedicated to providing medical assess-
ment and management to high-risk patients in elective 
surgery.
There is a strong rationale for the beneficial effects 
of preoperative medical consultations by internal medi-
cine physicians in reducing postoperative length of stay 
and complications, and improving long-term recovery 
and rehabilitation. However, no systematic review of the 
literature reporting evaluations of preoperative medical 
consultation has been reported. Thus, we conducted a 
systematic review of the published literature reporting on 
preoperative medical consultations by internal medicine 
physicians in high-risk surgical patients.
MethODs
Data sources and searches
Systematic searches of MEDLINE, EMBASE, CINAHL, 
PubMed, Current Contents and the NHS Centre for 
Reviews and Dissemination (including Cochrane Data-
base of Systematic Reviews, Database of Abstracts of 
Review and Effects, Health Technology Assessment Data-
base and NHS Economic Evaluation Database) were 
conducted from database inception to 30 April 2017. 
A full list of search terms used is provided in the online 
supplementary appendix 1.
Searches were conducted without language restric-
tion. The reference lists of all included articles were then 
manually searched for relevant references that may have 
been missed during the database searches.
study selection
Studies were selected for inclusion on the basis of the 
following criteria:
Type of studies
Randomised controlled trials (RCTs) and non-randomised 
comparative studies (eg, quasi-RCTs, controlled before 
and after studies and cohort studies) were considered in 
the review.
Participants
Humans aged 18 years and over scheduled for elective 
surgery.
Intervention
Preoperative medical consultations by an internal medi-
cine physician or generalist for elective surgical patients. 
The assessment may take place in any setting, such as on 
a ward or in an outpatient clinic.
Comparator
Preoperative assessment by an anaesthetist, other existing 
preoperative assessment process or no preoperative 
medical consultation.
Outcomes
 ► Convalescence (length of hospital stay);
 ► Perioperative morbidity and mortality (same-day 
admissions, surgical cancellations, complications, 
mortality);
 ► Cost/resource use (cost-effectiveness analyses, 
cost-savings, resource use);
 ► Quality of life (generic or disease-specific quali-
ty-of-life survey instruments, patient satisfaction).
Two reviewers (CP, JK) independently screened all 
titles and abstracts to determine eligibility. Full texts were 
retrieved for potentially relevant articles. Disagreements 
were resolved through discussion.
Data extraction and quality assessment
Data were extracted by one reviewer (CP) and checked 
by a second (JK) using standardised data extraction tables 
that were developed a priori.
The evidence presented in the included studies were 
classified according to the National Health and Medical 
Research Council (NHMRC) Evidence Hierarchy.5 Study 
quality was assessed using the Cochrane Collaboration’s 
tool for assessing risk of bias in RCTs (chapter 8,6 table 
8.5a) and in non-randomised studies (chapter 13,6 
table 13.2a). All studies were assessed based on the four 
main sources of systematic bias in studies of the effects 
of healthcare, namely selection bias, performance bias, 
detection bias and attrition bias. Discrepancies were 
resolved through a consensus process.
Data synthesis and analysis
The heterogeneity of the interventions and the variability 
of outcome measures precluded meta-analysis. The 
outcome data from the studies were therefore reported 
narratively. Differences between intervention and control 
groups for each outcome measure were reported as differ-
ence in means, OR or risk ratio.
results
Of the 128 citations screened for eligibility, 4 met the 
inclusion criteria; 1 RCT and three non-randomised 
comparative studies (1 prospective and 2 retrospective). 
Figure 1 provides a summary of the search results and 
study selection.
Quality assessment
The quality of the available evidence was poor. Table 1 
summarises the risk of bias assessments for the included 
studies. The one RCT7 described their randomisation 
process but did not state their method of allocation 
concealment. Outcome assessments were not blinded 
but interobserver and intraobserver reliability tests were 
performed with 100% agreement reported from both 
tests. Blinding of investigators and patients was not 
possible due to the nature of the intervention. There 
were no losses to follow-up. The external validity of this 
RCT is uncertain as the study setting differed to the 
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Figure 1 Summary of search results and study selection.
non-experimental setting, for example, the time between 
admission and surgery was more restrictive in the study.
Two non-randomised studies used concurrent 
controls, but alternative methods for patient allo-
cation were used. Auerbach et al8 included patients 
prospectively via the Center for Medicare and 
Medicaid Services criteria, randomly selecting 
medical records of patients for the public reporting 
of data regarding adherence to surgical site infection 
processes. Katz et al9 collected retrospective data on all 
consecutive patients in their specified study periods. 
Auerbach et al8 used propensity scores as weights to 
control for selection bias but only the discriminative 
power of the propensity score model was reported 
and not whether covariate balance was achieved. 
Katz et al9 reported significant differences between the 
medical consultation and no consultation group for 
age, ASA status, type of surgery and gender, but did not 
adjust for these differences in their outcome analysis. 
The remaining non-randomised study used a prein-
tervention/postintervention design and included all 
retrospective patients in the specified time periods.10 
Vazirani et al10 used regression models with age, 
gender, time period (pre or post) and the American 
Society of Anesthesiologists (ASA) classification as 
covariates to adjust for differences between groups.
Due to the non-randomised comparative study 
design, outcome assessments were not blinded so there 
is the potential for error and bias in the collection and 
interpretation of information. Two studies retained 
all patients8 10 and the remaining reported losses to 
follow-up of around 8%.
Description of included studies
For the RCT, the mean ages of the patients were 65.3 
years for the intervention group and 65.7 years for the 
comparator group. There were no significant differences 
between groups for number of medications on admis-
sion, cardiac risk index category and ASA score. Patients 
in the comparator group could still receive a preoperative 
medical consultation, if necessary, but only as an inpatient 
(ie, only after admission for surgery), compared with the 
intervention group who attended an outpatient clinic 
within 3 weeks of surgery (figure 2). A range of surgical 
procedures across multiple specialties were included, with 
no significant differences in the proportion of patients in 
each surgical service.
For the non-randomised comparative studies, patients 
in the comparator group in one study8 received consul-
tation from an internist on days other than the interven-
tion or from another specialty but the actual timing of 
the consultation was not reported (table 2). Comparator 
groups in the remaining studies received either preop-
erative anaesthetic assessment only or did not receive 
any preoperative medical consultation, although no 
further details were reported (table 2). The timing of the 
preoperative medical consultation in the intervention 
groups differed across the three studies (figure 2). Age 
ranged from a mean 61.4 years to a mean 70.1 years in 
the intervention group and a median 58 years to a mean 
67.3 years in the comparator group. A range of surgical 
procedures across multiple specialties were included. 
Two of the studies focused on clinical outcome measures 
and the other focused on reviewing the medical consul-
tation process (eg, reason for consultation, consultants’ 
recommendations).
effectiveness of intervention
Table 3 provides a summary of the effectiveness of preop-
erative medical consultations by an internal medicine 
physician for a range of outcomes.
Surgical cancellations
Randomised controlled trial
A similar proportion of patients in each group did not 
undergo surgery (24.4% for a medical consultation 
within 3 weeks and 23.5% for a medical consultation after 
admission but before surgery). Of the surgical cancella-
tions that occurred after the admission for surgery, the 
patients who received a medical consultation after admis-
sion (control group) had a higher proportion of cancella-
tions (6.6% higher, 95% CI 0.5% to 12.7%).
Non-randomised comparative studies
One non-randomised comparative study reported on 
surgical cancellations.10 There were no significant differ-
ences in the number of surgical cancellations between 
patients who received an anaesthetic consultation and 
those who received a medical consultation.
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Table 1 Assessment of risk of bias in included studies
Source of bias Macpherson and Lofgren7 Auerbach et al8 Katz et al9 Vazirani et al10
Selection bias
  Randomisation (RCT) Permuted blocks of size 2 
and 4, stratified by quartiles 
of anticipated LoS
– – –
  Allocation concealment 
(RCT)
Not reported – – –
  Control for confounders 
(NRS)
– Patients sampled at 
random; propensity 
score weighting
Consecutive patients Regression 
methods
  External validity (RCT and 
NRS)
Uncertain as study setting 











  Blinding of participants 
and/or investigators (RCT)
No – – –
  Measurement of exposure 
(NRS)
– No blinding but 5% 
of medical record 
abstractions were 
reviewed for data 
validity
No blinding No blinding
Detection bias
  Blinded outcome 
assessment (RCT and NRS)
No blinding but 100% 
interobserver and 
intraobserver agreement*
Not reported Not reported Not reported
Attrition bias
  Completeness of follow-up 
(RCT and NRS)
Yes Yes 35 (8.3%) patients with 
missing medical records
Yes
Ellipses indicate not applicable.
*A researcher re-abstracted length of stay data on 10 randomly selected records, and a physician not associated with the study abstracted 
length of stay from the same 10 records.
LoS, length of stay; NRS, non-randomised studies; RCT, randomised controlled trials.
Length of hospital stay
Randomised controlled trial
Across all patients, the preoperative length of stay was 
reduced in the intervention group (1.3-day reduction, 
95% CI −1.8 to −0.8), but there was no significant differ-
ence between the intervention and control groups for the 
postoperative and overall length of stay.
Non-randomised comparative studies
Length of stay was reported in two of the non-ran-
domised comparative studies.8 10 After adjustment for 
observed potential confounding, a medical consulta-
tion on or around the day of surgery compared with 
a medical or other specialty consultation in two or 
more days before surgery resulted in a 13% increase 
in length of stay (95% CI 2% to 26%).8 There were 
no significant differences in overall length of stay 
between the medical and anaesthetic consulta-
tions but patients who were ASA 3 or higher had a 




The RCT did not report on costs.
Non-randomised comparative studies
Only one non-randomised comparative study reported on 
costs.8 There was a 24% increase in costs for patients who 
received a medical consultation on or around the day of 
surgery compared with those who received a medical or 
other specialty consultation in two or more days before 
surgery, with increases ranging from 14% to 36%.
Postoperative complications
Randomised controlled trial
The RCT did not report on postoperative complications.
Non-randomised comparative studies
The odds of complications after postoperative day 2 for 
patients receiving a medical consultation on or around 
the day of surgery was 1.51 times greater than for patients 
receiving a medical or other specialty consultation in 
two or more days before surgery (95% CI 0.98 to 2.32).8 
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Figure 2 The timing of the preoperative medical consultation in each included study. *Macpherson and Lofgren7 compared 
preadmission medical consultations (outpatient clinic) to postadmission preoperative medical consultations (inpatient) and 
Auerbach et al8 compared a medical consultation on the day before, day of or day after surgery with a medical or other specialty 
consultation on days other than the intervention (ie, two or more days before surgery).
Suspected infection, cardiac, pulmonary and other 




The RCT did not report on mortality.
Non-randomised comparative studies
The likelihood of death in patients who received a 
medical consult was significantly lower (69% less likely) 
than those who received an anaesthetic consult.10
Patient satisfaction
Randomised controlled trial
No significant differences in quality of life and quality 
of care measures at 2 months postrandomisation were 
reported between patients who received a medical consul-
tation in the 3 weeks prior to admission, and following 
admission.
Non-randomised comparative studies
None of the non-randomised comparative studies 
reported on patient satisfaction.
review of the medical consultation process
In the non-randomised study of preoperative assessment 
in the 4 weeks prior to admission,9 medical records were 
reviewed to determine the characteristics of the medical 
consultations. The specialty of the requesting physician 
and the reason for medical consultation could not be 
determined for the majority of the consultations (51% 
and 64%, respectively). Of the remaining, requests for a 
medical consultation were either from surgeons (46%) 
or other internists or family practitioners (3%), and 
the main reasons for requesting a medical consultation 
were for clearance (19%) or evaluation (14%). Other 
reasons included risk assessment (0.7%) and re-assess-
ment (0.7%). Patients’ diagnoses were listed in 83% 
of the consultations, with 3% diagnosing a medical 
condition not previously identified in the admitting 
history. In terms of recommendations, no recommen-
dations were reported in 43% of the consultations, 34% 
‘cleared’ the patient for surgery and 20% provided a 
risk assessment such as ‘minimal increased risk’ or ‘no 
increased risk’. Of the 178 preoperative, intraoperative 
and postoperative recommendations made, documen-
tation in the medical records indicated that 73% were 
followed, 9% were not followed and in 18% it could not 
be determined.
DIscussIOn
The effectiveness of preoperative medical consultation is 
uncertain due to a lack of high-level comparative evidence. 
The one RCT7 identified reported medical consultations 
in an outpatient setting were effective in reducing surgical 
cancellations following admission for surgery compared 
with medical consultations in an inpatient setting. The 
RCT also reported a small reduction in length of stay 
for patients who received preadmission preoperative 
medical consultations, noting that the active control 
(inpatient medical consultations) may have reduced the 
effect size relative to a non-active control. The observa-
tional studies reported mixed results regarding length of 
stay8 10 and mortality,9 10 and increased costs8 and post-
operative complications8 in patients who received preop-
erative medical consultations, but these results must be 
interpreted with caution due to the potential for bias and 
confounding.
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Table 3 Summary of effectiveness of physician-led preoperative assessment by outcome
Outcome and study Intervention Comparator Difference*
Length of stay (days)
Macpherson and Lofgren7 (mean)
  All patients
   Preadmission for surgery 1.6 2.9 −1.3 (−0.8 to −1.8)
   Admission for surgery 3.6 3.0 0.6 (−0.6 to 1.8)
   Total 5.5 6.0 −0.5 (−2.0 to 1.1)
  Patients who had surgery
   Preadmission for surgery 1.9 3.0 −1.1 (-0.5 to −1.6)
   Admission for surgery 4.8 3.9 0.9 (−0.6 to 2.4)
   Total 7.1 7.0 0.1 (−1.7 to 2.0)
Auerbach et al8 (median, IQR)
  Before adjustment 10 (7–18) 6 (4–9) 87% (63% to 115%)†
  After adjustment NR NR 13% (2% to 26%)†
Vazirani et al10
  Mean (SD) 5.28 (9.24) 9.87 (25.4) NR
  ASA classification
   No disturbance NR NR −1.31 (SE 5.90), P=0.82
   Mild NR NR −2.52 (SE 1.39), P=0.07
   Severe NR NR −4.22 (SE 0.96), P<0.01
   Life-threatening NR NR −19.70 (SE 3.81), P<0.01
Costs (USD)
Auerbach et al8 (median)
  Before adjustment 1 55 020 (101 473–292 951) 74 237 (53 824–126 927) 116% (88% to 148%)†
  After adjustment NR NR 24% (14% to 36%)†
Postoperative complications
Auerbach et al8 (n, %)
  Before adjustment 60 (51.3) 322 (27.6) OR 2.76 (1.88 to 4.04)
  After adjustment NR NR OR 1.51 (0.98 to 2.32)
Mortality
Katz et al9 (n, %)
  Unexpected ICU/death 2 (1.4) 4 (1.6) P=0.9046
Vazirani et al10 (n, %) 4 (0.4) 14 (1.3) OR 0.31 (0.10 to 0.99)
Surgical cancellations
Macpherson and Lofgren7 (n, %)
  During admission 10 (5.7) 22 (12.3) −6.6% (−0.5% to −12.7%)
  Did not undergo surgery 43 (24.4) 42 (23.5) NR
Vazirani et al10 (n, %)
  Total 368 (14.3) 400 (15.0) NR
  Medically avoidable‡ 18 (4.9) 34 (8.5) P=0.065
Patient satisfaction
Macpherson and Lofgren7
  MOS SF-22 (higher score indicates better health)
   Health perceptions 38.8 33.1 NS
   Pain 55.3 59.8 NS
   Physical function 45.7 44.1 NS
Continued
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Outcome and study Intervention Comparator Difference*
   Social function 62.3 61.2 NS
   Mental health 63.0 58.0 NS
  Questionnaire adapted from RAND§ (%)
   Satisfaction with care 73 66 NS
   Dissatisfaction with care 39 47 NS
   Rated care as very good or 
excellent
64 54 NS
   Rated care as better than most 
or best
62 54 NS
   Overall, very or extremely 
satisfied
66 58 NS
*Difference reported as mean difference (95% CI of the difference) unless otherwise specified.
†Cost and length of stay data were log transformed to normalise data with percentage differences attributable to consultation calculated 
using the following equation: 100x(eβ−1).
‡As opposed to unavoidable, patient-related causes.
§Patient satisfaction questionnaire adapted from RAND.
ASA, American Society of Anesthesiologists; ICU, intensive care unit; MOS SF-22, Medical Outcomes Study Short Form-22; NR, not 
reported; NS, not significant, actual P value not reported; USD, United States Dollar.
Table 3 Continued 
Design limitations in included studies
As well as differences in the comparator arms, the 
reviewed studies varied with respect to the timing and 
delivery of the preoperative medical consultation, which 
precluded the pooling of results. One study evaluated the 
effect of medical consultations on the day before or day 
of surgery,8 while differences in the timing of preadmis-
sion consultations may be driven by varying waiting times 
across forms of elective surgery (eg, cancer vs non-cancer 
procedures) and geographical locations. In general, it 
might be hypothesised that consultations undertaken 
close to the date of surgery provide less time for optimisa-
tion. A recent review of guidelines pertaining to preoper-
ative medical management suggested that consultations 
may be most beneficial when sought at least 4 weeks 
prior to elective surgery, and when there is a clear under-
standing of the planned procedure and its associated 
risks.11
The form of preoperative medical consult also varied 
across the included studies, with minimal detail from 
each of the studies on the actual services provided as 
part of the intervention. It was not clear in any of the 
included studies if the consultant providing the inter-
vention was also involved in the postoperative care of the 
patient. A one-off consult with recommendations but no 
patient follow-up may be less effective than a coordinated 
approach to shared decision making between specialists 
and physicians for perioperative management. Katz et al9 
provided some insight into the reasons for requesting a 
consult, but were limited by the information documented 
in the medical records.
The comanagement concept of surgeons managing 
a patient’s surgery and surgery-related issues and the 
internal medicine physician or geriatrician managing a 
patient’s medical conditions is rational.12 The results of 
the review do not confirm nor reject the hypothesis that 
preoperative medical consultation provides important 
benefits. The findings suggest that there is significant 
uncertainty around the overall effect of such services, as 
well as illustrating the variation in the design and imple-
mentation of preoperative assessment.
the role of the general internist compared with other 
subspecialists
Internationally, the subspecialist providing the preop-
erative medical consultation will vary. Anaesthetists 
have a different focus and expertise by providing safe 
anaesthesia and specific perioperative management,13 14 
which complements the role of the general internist who 
assesses and optimises the patient’s modifiable comorbid-
ities. Despite a great deal of overlap between geriatrics 
and general internal medicine, the focus of a comprehen-
sive geriatric assessment (CGA) may differ to a preoper-
ative medical consultation in some surgical populations. 
A CGA intervention that focuses on the assessment 
component only will differ to the focus of a general inter-
nist who will assess the patient and recommend specific 
management plans to optimise modifiable risk factors for 
adverse postoperative outcomes.15 For this reason, studies 
involving a preoperative medical consultation by subspe-
cialists other than the general internist as the interven-
tion were excluded.
recommendations for improvements in clinical practice and 
research design
Currently, there are no clear recommendations regarding 
the selection of patients who require medical consul-
tation.16 Given limited resources, patients at high risk 
of morbidity and mortality should be prioritised for a 
medical consultation but substantial practice variation 
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exists.17 The decision to refer a patient for preoperative 
consultation is at the discretion of the treating surgeon 
and influenced by the surgeon’s personal preference 
for the intervention, patient preference, patient char-
acteristics and medical history. Auerbach et al8 reported 
increases in postoperative complications with a medical 
consult but the consultations may have been requested for 
an impending or suspected complication, which would 
make it difficult to discern whether a consult reduced the 
risk of complications. Thus, confounding by indication 
is a major source of bias in the non-randomised compar-
ative studies.18 Auerbach et al8 used propensity scores as 
weights to adjust for confounding but the authors indi-
cated that patterns of consultation and other unmea-
sured confounding factors in the patient’s medical history 
or illness may have biased their results. A key potential 
confounder that may not be adequately represented in 
the reported studies is frailty, which has been shown to be 
a predictor of surgical morbidity and mortality, and may 
also be an important factor in the decision to refer for 
preoperative medical consultation.19–21
Well-designed and conducted RCTs can remove poten-
tial confounding, but issues remain around the feasibility 
of such trials and the generalisability of the findings. 
Having a no-consultation arm in the trial for a patient 
identified as high risk would be a major challenge, and 
strict trial conditions cannot be easily translated into 
clinical practice. In the RCT in this review, patients in 
the comparator group could still receive a preoperative 
medical consultation as an inpatient, if necessary, and the 
strict trial conditions on the timing between admission 
and surgery may not reflect the application of the inter-
vention in routine clinical practice.
Evidence directly linking preoperative interventions 
with a reduction in perioperative risk are lacking. Given 
the multidisciplinary care of patients in a hospital setting, 
it is difficult to assess whether one particular aspect of 
care provided directly impacts on a particular outcome. 
The design of services applied to date is heterogeneous, 
but the consolidation of existing evidence has identi-
fied potential elements of preoperative assessment that 
may contribute to better outcomes, for example, eligi-
bility criteria for referral, and the timing and process of 
assessment. In the absence of robust evidence, preoper-
ative medical consultations are likely to remain ad hoc 
in terms of implementation and design. Qualitative data 
may provide an in-depth understanding of the processes 
of care and the perceived value of preoperative consulta-
tion. Future research should aim to clearly describe the 
level of involvement of the internal medicine physician 
in the surgical decision-making process and their rela-
tionship with the surgical team. A better understanding 
of the mechanisms of preoperative medical consultations 
and the complex decision-making processes involved may 
help explain the relationship between medical consul-
tations and outcomes. Further research is also required 
to determine the characteristics of patients who would 
benefit most from medical consultation.
cOnclusIOn
Preoperative medical consultations for patients with 
complex care requirements and in poor health is an intu-
itive health service development. To date, such services 
appear to have been developed and implemented on a 
limited and ad hoc basis, resulting in varied service designs 
and a lack of evidence on the value of preoperative assess-
ment. With an ageing population and increasing rates of 
chronic disease, the management of high-risk surgical 
patients is likely to become an increasingly important 
issue. The available evidence suggests a positive effect of 
preoperative medical consultation with a general inter-
nist compared with standard care, but more conclusive 
evidence may be needed to persuade hospitals to fund 
such a service. Alternative forms of preoperative assess-
ment may also need to be considered, such as compre-
hensive geriatric assessment, and there may be scope to 
optimise the value of such services by closer consideration 
of referral criteria and the timing of preoperative assess-
ment. Providing continuity of multidisciplinary care from 
the decision to operate through to rehabilitation and 
recovery is certainly logical and intuitive. However, further 
research is required to inform the value, and the optimal 
design and implementation of coordinated involvement 
of physicians and surgeons in the provision of care for 
high-risk surgical patients. A standardised approach to 
perioperative decision-making processes should be devel-
oped with a clear protocol or guideline for the assessment 
and management of surgical patients.
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4.3.1 Online supplementary material
Appendix 1. Search strategies
Search strategy for Centre for Reviews and Dissemination
#1 MeSH descriptor: [preoperative care] explode all trees
#2 MeSH descriptor: [referral and consultation] explode all trees
#3 (#1 AND #2)
Search strategy for PubMed
#1 preoperative[All Fields]
#2 medical[All Fields]
#3 (“referral and consultation”[MeSH Terms] OR (“referral”[All Fields] AND
“consultation”[All Fields]) OR “referral and consultation”[All Fields] OR
“consultation”[All Fields])
#4 (“surgical procedures, elective”[MeSH Terms] OR (“surgical”[All Fields] AND
“procedures”[All Fields] AND “elective”[All Fields]) OR “elective surgical
procedures”[All Fields] OR (“elective”[All Fields] AND “surgery”[All Fields]) OR
“elective surgery”[All Fields])
#5 (#1 AND #2 AND #3 AND #4)
#6 preoperative[Title]
#7 “medical consultation”[Title]
#8 (#6 AND #7)
#9 “preoperative evaluation”[All Fields]
#10 “internal medicine”[All Fields]
#11 (#9 AND #10)
#12 (“Hospitalists”[MeSH] OR “internal medicine”[MeSH]) AND “preoperative
evaluation”[All Fields]
Search strategy for EMBASE (Elsevier)
#1 ‘preoperative care’/exp OR ‘preoperative care’
#2 ‘elective surgery’/exp OR ‘elective surgery’
#3 ‘referral and consultation’/exp OR ‘referral and consultation’
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#4 (#1 AND #2 AND #3)
Search strategy for CINAHL (EBSCO host)
S1 MW ‘preoperative care’
S2 MW ‘elective surgery’
S3 MW medical OR MW ‘referral and consultation’
S4 (S1 AND S2 AND S3)
Search strategy for Current Contents Connect (Web of Science)
#1 TOPIC: ‘preoperative care’
#2 TOPIC: ‘elective surgery’
#3 TOPIC: ‘referral and consultation’
#4 (#1 AND #2 AND #3)
Search strategy for MEDLINE (Ovid)
#1 exp “preoperative care”/
#2 exp “surgical procedures, elective”/
#3 exp “referral and consultation”/









This chapter describes the evaluation of the costs and effects of an outpatient clinic
providing physician-led preoperative assessment and management in Adelaide, South
Australia. The article, published in the Journal of Evaluation in Clinical Practice,
details the propensity-based approaches, including a recently introduced covariate
balancing methodology, used to control for confounding in a retrospective observa-
tional dataset. The focus of the analysis was to estimate the costs and effects of
the physician-led clinic using a mixed retrospective and prospective observational
study design. The application of alternative propensity-based approaches to a large
sample of retrospective data, supplemented with a smaller sample of prospective
data, informed a pragmatic approach to reducing potential observed confounding
and assessing the potential for unmeasured confounding in the evaluation.
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Abstract
Rationale, aims and objectives A physician-led clinic for the preoperative optimization
and management of high-risk surgical patients was implemented in a South Australian pub-
lic hospital in 2008. This study aimed to estimate the costs and effects of the clinic using a
mixed retrospective and prospective observational study design.
Method Alternative propensity score estimation methods were applied to retrospective
routinely collected administrative and clinical data, using weighted and matched cohorts.
Supplementary survey-based prospective data were collected to inform the analysis of
the retrospective data and reduce potential unmeasured confounding.
Results Using weighted cohorts, clinic patients had a significantly longer mean length of
stay and higher mean cost. With the matched cohorts, reducing the calliper width resulted
in a shorter mean length of stay in the clinic group, but the costs remained significantly
higher. The prospective data indicated potential unmeasured confounding in all analyses
other than in the most tightly matched cohorts.
Conclusions The application of alternative propensity-based approaches to a large sample
of retrospective data, supplemented with a smaller sample of prospective data, informed a
pragmatic approach to reducing potential observed and unmeasured confounding in an
evaluation of a physician-led preoperative clinic. The need to generate tightly matched
cohorts to reduce the potential for unmeasured confounding indicates that significant
uncertainty remains around the effects of the clinic. This study illustrates the value of
mixed retrospective and prospective observational study designs but also underlines the
need to prospectively plan for the evaluation of costs and effects alongside the implemen-
tation of significant service innovations.
Introduction
Advances in medical technology and public health initiatives have
increased life expectancy. However, the consequences in terms of
the health and medical needs of an ageing population are a global
issue for health care providers and health care systems worldwide.
More than 80% of Australians aged 65 years and over have three
or more co-morbidities [1]. In the USA, 62% of the population
aged between 65 and 74 years and 81% aged 85 years and over
have two or more co-morbidities [2], with similar numbers re-
ported in the UK [3]. In surgical patients, co-morbidities affect
the rate and extent of post-surgical recovery, resulting in higher
health service costs and poorer patient outcomes [4]. Targeted
preoperative management of potentially modifiable co-morbidities
may improve postoperative outcomes [5–8]. A high-risk clinic for
the preoperative medical optimization and management of high-
risk surgical patients has been operating in a South Australian pub-
lic hospital since 2008, but the costs and consequences of the
clinic have not been formally evaluated. Evaluation is required
to justify the continuation of the clinic, as well as to inform the po-
tential value of expanding preoperative management to other
facilities.
The aim of this paper is to assess the value of a mixed retrospec-
tive and prospective study design for the evaluation of an existing
health service, which provides an empirical assessment of a poten-
tial unmeasured confounder. The study also compares the
Journal of Evaluation in Clinical Practice ISSN1365-2753
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5.2.2 Publication
application of alternative propensity score-based approaches to the
retrospective data with respect to minimizing potential observed
confounding.
Methods
The retrospective study aimed to analyse the costs and conse-
quences of a preoperative clinic for high-risk surgical patients
(compared with no preoperative clinic) using alternative
propensity-based methods to adjust for potential observed con-
founders. A supplementary prospective study of quality of life in
patients attending and not attending the high-risk clinic informed
the likelihood of unmeasured confounding in the retrospective
study.
Retrospective study
Setting. A cost–consequence analysis was performed using a
retrospective cohort of patients scheduled for elective surgery be-
tween January 2008 and December 2011 at the Royal Adelaide
Hospital (RAH).
Patients were referred to the high-risk clinic (‘clinic’) at the dis-
cretion of the surgical consultant or anaesthesiologist around the
time of the decision to undergo surgery (no formal referral path-
way was defined). All patients scheduled for elective surgery were
seen by the preoperative anaesthetic service approximately 1week
before surgery, where anaesthesiologists provided standard preop-
erative care.
In the high-risk clinic, a consultant physician and nurse, who
both specialized in the provision of medical optimization and man-
agement of high-risk patients, assessed patients in an outpatient
setting prior to surgery and through to recovery and rehabilitation
in the postoperative period. There were four clinics per week with
an average of 24 patients seen per week (16 new patients and 8 pa-
tients with follow-up visits). All referrals were triaged according to
surgical priority, with patients awaiting curative surgery for malig-
nancy prioritized over those awaiting non-life saving elective
surgery.
Patients who were not referred to the clinic either proceeded to
surgery without further specialist consultation or were referred, at
the surgeon’s discretion, to a specialist for management of a spe-
cific condition (e.g. cardiologist and nephrologist). Patients may
not have been referred to the clinic for a variety of reasons, such
as further management was not required, the surgeon was not
aware of the clinic and its services, and the surgeon’s preference
was to refer to a specialist for management of a specific condition
(e.g. cardiologist and nephrologist).
Participants. Eligibility criteria for the analysis of the clinic in-
cluded patients who were aged 18 years and over at the time of re-
ferral and who were scheduled for one of five elective surgical
procedures [transurethral resection of the prostate (TURP); total
hip or knee replacements (THR, TKR); and surgery for abdominal
aortic aneurysm (AAA), head and neck cancer (HNC) and colorec-
tal cancer (CRC)]. The selected procedures account for approxi-
mately two-thirds of the patient population referred to the clinic.
In cases where a patient had several eligible procedures, the
procedure associated with a referral to the high-risk clinic was
coded as the index event; otherwise, the first procedure was coded.
Data sources. Detailed patient and clinical information on all
public and private hospital separations were extracted from hospi-
tal and state-level data systems. Data from the patient who com-
pleted Preoperative Assessment Patient Questionnaire were
extracted from patient records, which provided additional informa-
tion on patients’ health status, existing condition(s) and current
medication(s). Laboratory test results were obtained from the
Red Cross Blood Service and South Australian Pathology, and
patient-level inpatient cost estimates were provided by the Depart-
ment of Health. The high-risk clinic database provided data on pa-
tients who were referred to the clinic, including the number and
dates of clinic appointments.
The primary measure of outcome was length of stay (LoS), with
secondary outcomes including postoperative complications, total
inpatient costs (for the index separation) and 12-month mortality.
Costs for running the clinic, based on staff salaries, were calcu-
lated for new and follow-up appointments and added to inpatient
costs for each clinic patient.
Data analysis. The observational data were analysed using a
two-step process:
1 Propensity score estimation to adjust for observed confounding
(model for treatment) [9].
2 Regression analyses to examine the association between pa-
tients who attended the clinic and surgical outcomes (models
for outcomes).
Covariables. Covariables that could potentially influence
whether a patient was referred to the clinic were selected a priori
and were based on clinical consultation and previous studies
[10,11]. Covariables included patient demographics, surgery-
related factors, whether the patient had a fall in the previous
12months, patient’s physical function and nine medical co-
morbidities targeted by the high-risk clinic with the greatest poten-
tial to be modified: ischaemic heart disease, congestive heart fail-
ure, stroke, diabetes mellitus, renal impairment, anaemia,
dementia including Alzheimer’s disease, asthma or chronic ob-
structive pulmonary disease, and primary hypertension (Table 1)
[12]. The number of days since the clinic was established was also
included as a covariable to account for changes in surgical and
medical treatment and management.
Propensity score estimation. Propensity scores were initially
estimated using standard logistic regression and boosted logistic
regression. Logistic regression focuses on finding parameter esti-
mates that maximize the fit of the data (maximum likelihood esti-
mation) rather than maximize the covariate balance, which should
occur if the model is correctly specified [13]. Boosted logistic re-
gression improves on the standard by using a data-adaptive algo-
rithm, which accommodates for various types of covariates
(continuous, nominal and ordinal), and a non-parametric model
to reduce the risk of model misspecification errors [14]. Despite
the improvement in the propensity score models from standard to
boosted, both approaches failed to achieve covariate balance with
C. T. Pham et al.Evaluation of an existing health service
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standardized differences of >10% between the clinic and control
groups in 14 and 10 of the 24 covariables for the standard and
boosted logistic regressions, respectively.
The covariate balancing propensity score (CBPS) method [15]
is an alternative approach that replaces the maximum likelihood
estimation in the logistic regression with a non-parametric method
of moments estimation that uses the entire distribution of baseline
covariates, an important factor when dealing with skewed data.
The fundamental aim of CBPS is to estimate the propensity score
that preserves the property of balancing covariates. The CBPS















Age (mean years) 73.6 69.2 0.41 0.75 0.00 73.5 0.01 0.96 0.95
Female 37.2 38.4 -0.03 0.99 0.80 37.2 0.00 1.00 0.99
Surgical procedure 0.98 0.69 1.00 1.00
Abdominal aortic aneurysm 7.4 9.1 -0.06 0.83 0.54 7.7 -0.01 0.97 0.93
Transurethral resection of prostate 9.1 8.9 0.01 1.04 0.93 9.1 0.00 1.01 0.99
Total knee replacement 22.3 22.7 -0.01 1.00 0.92 22.1 0.01 1.01 0.96
Total hip replacement 22.3 27.0 -0.11 0.89 0.28 22.5 0.00 1.00 0.97
Head and neck cancer surgery 16.5 12.0 0.14 1.32 0.17 16.2 0.01 1.02 0.94
Colorectal cancer surgery 22.3 20.3 0.05 1.08 0.61 22.5 0.00 1.00 0.98
Surgical severity 0.98 0.79 1.00 1.00
Mild 20.7 19.1 0.04 1.07 0.70 20.7 0.00 1.01 0.99
Moderate 76.9 77.3 -0.01 1.02 0.92 76.7 0.00 1.00 0.98
Significant 2.5 3.6 -0.06 0.70 0.54 2.6 0.00 0.97 0.96
Urgency category 0.95 0.35 1.01 1.00
Within 30 days 48.8 44.3 0.09 1.02 0.75 48.7 0.00 1.01 0.99
Within 90 days 18.2 15.7 0.07 1.13 0.95 18.5 -0.01 0.99 0.95
Within 1 year 33.1 40.0 -0.14 0.93 0.58 32.9 0.00 1.01 0.97
SEIFA (mean score) 959.7 968.0 -0.11 0.84 0.25 960.2 -0.01 0.74 0.95
BMI (mean score) 29.5 28.5 0.17 1.15 0.09 29.4 0.02 0.73 0.89
Smoking status 0.96 0.85 1.02 0.99
Never 39.7 38.1 0.03 1.02 0.75 38.8 0.02 1.01 0.88
Former 48.8 48.4 0.01 1.01 0.95 49.7 -0.02 1.01 0.88
Current 11.6 13.4 -0.05 0.89 0.58 11.5 0.00 1.01 0.99
Marital status 1.11 0.18 1.03 1.00
Never married 10.7 11.1 -0.01 0.97 0.90 10.4 0.01 1.03 0.92
Married/de facto 51.2 60.1 -0.18 1.05 0.07 51.9 -0.01 1.01 0.91
Widowed 19.0 15.1 0.11 1.20 0.28 19.3 -0.01 0.99 0.95
Divorced 16.5 10.1 0.20 1.53 0.04 15.8 0.02 1.04 0.88
Separated 2.5 3.4 -0.05 0.73 0.59 2.5 0.00 0.99 0.97
Medical co-morbidities
Ischemic heart disease 66.1 32.0 0.71 1.03 0.00 65.4 0.02 1.00 0.89
Congestive heart failure 5.0 0.7 0.37 6.74 0.00 4.6 0.03 1.08 0.91
Stroke 19.0 6.0 0.48 2.74 0.00 17.9 0.04 1.05 0.83
Diabetes mellitus 33.1 20.1 0.31 1.39 0.00 32.1 0.02 1.02 0.87
Renal impairment 34.7 16.7 0.46 1.64 0.00 34.6 0.00 1.01 0.98
Anaemia 40.5 26.4 0.31 1.25 0.00 40.1 0.01 1.01 0.94
Dementia including Alzheimer’s 3.3 0.6 0.28 5.76 0.01 3.0 0.03 1.11 0.91
Asthma/COPD 44.6 30.6 0.30 1.17 0.00 44.7 0.00 1.00 0.99
Hypertension 16.5 7.1 0.34 2.09 0.00 15.5 0.04 1.06 0.83
Fall in previous 12months 5.8 2.3 0.21 2.43 0.03 4.8 0.06 1.18 0.73
Able to walk around house 57.9 70.0 -0.26 1.17 0.01 58.2 -0.01 1.01 0.96
Able to walk upstairs 37.2 50.9 -0.27 0.94 0.01 37.1 0.00 1.01 0.98
Physical disabilities 38.8 25.4 0.30 3.71 0.00 38.1 0.02 1.01 0.90
Artificial joints/implants 20.7 25.6 -0.11 0.87 0.25 20.7 0.00 1.01 1.00
Days since clinic was established (mean)* 1127.9 1048.3 0.23 0.82 0.02 1126.3 0.00 0.76 0.97
Data are presented as percentages of each group unless otherwise specified.
BMI, body mass index; SEIFA, socioeconomic indexes for areas; ENT, ears, nose and throat; COPD, chronic obstructive pulmonary disease.
*The number of days since the high-risk clinic was established on 1 January 2008.
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estimation method can also yield robust estimates of treatment ef-
fects, even when both the outcome and propensity score models
are misspecified and does so at the cost of some likelihood. This
method focuses on minimizing the imbalance of covariates when
calculating the parameter estimates and was able to balance all
24 covariables, with standardized differences and variance ratios
for covariables between the clinic and control groups all <10%
and <2.0, respectively.
The sensitivity of treatment effect estimates was tested using
two propensity score methods: weighting using the propensity
score [16] and matching on the propensity score [17]. With
weighting, overall estimates of the average treatment effect on
the treated (ATT) were calculated based on the CBPSs. With
matching, patients attending and not attending the clinic were
matched (1:1) on the predicted propensity of being referred to
the clinic. The nearest neighbour matching method without re-
placement was used with callipers set to 0.0001, 0.001 and 0.01,
respectively. This approach pairs clinic with control patients such
that the difference in probabilities between the matched patients
differs by a maximum at most a fixed distance (the calliper width).
An optimal calliper width of 20% of the standard deviation of the
predicted propensity scores has been proposed [18], but the
resulting calliper width of 0.035 was considered too wide,
resulting in clinically significant differences in covariables be-
tween the matched clinic and control patients. A calliper of
0.0001 generated highly similar matches but produced too few
matched patients (23 patients). Thus, calliper widths of 0.001
and 0.01 were applied to provide a range of estimates given the
variance–bias trade-off. One-to-one matching (over 1:N matching)
was used as it provides similar observations to construct the coun-
terfactuals and thus reduce bias. This reduction in bias comes at a
cost of a decrease in precision, but the reduction of bias was con-
sidered the dominant issue in this analysis.
Propensity score methods were performed using Stata [19]
and the R statistical programming language [20]. Stata’s
‘pscore’ command was used for the standard logistic regression.
In R, the ‘twang’ package [21] was used for the boosted logistic
regression and the ‘CBPS’ package [22] for the CBPS method.
Matching was performed in Stata using the ‘psmatch2’ com-
mand with the probabilities from the CBPS method imported
from R.
Outcome analyses. Propensity-weighted regression methods,
using ATT weights derived from the CBPS estimation, tested for
associations between outcomes and clinic patients. For count data
(LoS, total inpatient costs and number of postoperative complica-
tions), negative binomial regressions were used to account for the
over-dispersion. Logistic regression was used for the binary out-
come of 12-month mortality. Non-parametric bootstrapping
(1000 iterations) was then applied to estimate the 95% confidence
intervals (CI). Paired t-tests for count data and the McNemar test
for binary data were used to compare outcomes after propensity
score matching.
Results are presented as ATT with 95% CI. Costs are reported
in Australian Dollars (AUD). P-values of less than 0.05 were con-
sidered statistically significant. Regression analyses and
bootstrapping were performed using the R statistical programming
language [20].
Supplementary prospective study
Setting. The aim of this supplementary study was to collect pro-
spective health-related quality of life (HRQOL) data on a cohort of
patients listed for surgery, to test for potential unmeasured con-
founding due to the use of retrospective data for the main analysis.
Patients listed for elective surgery between June 2012 and October
2013 at the RAH were identified via hospital elective surgery
waiting lists.
Participants. Identified patients were eligible if they were aged
18 years and over and listed for at least one of the selected elective
surgical procedures (TURP, THR, TKR, AAA, HNC and CRC).
Data collection and analysis. Eligible patients were sent a sur-
vey including the EuroQOL five-dimension questionnaire (EQ-
5D-5L) [23] and a set of additional co-morbidity questions, via
postal mail. The EQ-5D-5L is the new, updated version of one
of the most widely used health status instruments (the EQ-5D)
and comprises five questions, each with five levels, representing
five health domains: pain, mood, mobility, self-care and daily ac-
tivities [24]. Data from the Preoperative Assessment Patient Ques-
tionnaire were also collected.
The EQ-5D profiles were transformed, using the value set for
the UK, into weighted health state index scores, ranging from
0.594 (worst health state) to 1.00 (best health state) [25].
The CBPS estimation method, as described in the main study
analyses, was used on this prospective dataset. Regression using
generalized linear modelling was used to test the association be-
tween health state index scores and clinic patients. Non-parametric
bootstrapping (1000 iterations) was then applied to estimate the
95% CI. Results are presented as ATT with 95% CI. P-values of
less than 0.05 were considered statistically significant. Regression
analyses and bootstrapping were performed using the R statistical
programming language [20].
Ethics approval for the main and sub-study was granted by the
South Australian Department of Health Human Research Ethics
Committee (HREC Protocol No. 490/01/2015) and the Royal Ad-




Of the 943 eligible patients, 821 patients had complete-case data
and 122 patients had data missing for at least one of the
covariables of interest. Body mass index and socioeconomic in-
dexes for areas score had the highest proportions of missing data.
Of the 821 patients, 121 (14.7%) were in the clinic group and
700 (85.3%) were in the control group, with total joint replace-
ments making up the majority of the selected elective procedures.
Table 1 details the characteristics of the control and clinic pa-
tients pre-propensity and post-propensity score weighting. Com-
pared with control patients, clinic patients were significantly
more likely to be older, have a higher body mass index, have mod-
ifiable co-morbidities targeted by the clinic, a fall in the previous
12months and physical disabilities. Clinic patients were also
C. T. Pham et al.Evaluation of an existing health service
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significantly less likely to be able to walk around the house and/or
upstairs. After weighting, there were no significant differences be-
tween the two groups for all the covariables, with standardized dif-
ferences of <10% and variance ratios of <2.0 for all 24
covariables indicating negligible differences and support of the as-
sumption of balance between the two groups [26]. The percentage
of overlap between the clinic and control propensity score distribu-
tions was 94% (Fig. 1).
High-risk clinic. The 121 patients referred to the clinic had a
mean 1.6 clinic appointments prior to their elective surgical
procedure.
Surgery was cancelled after admission for none of the clinic pa-
tients and seven of the control patients. Of these seven control pa-
tients, TURP surgery was cancelled in three patients at a total cost
of $9149, CRC surgery in two patients at a total cost of $1539,
HNC surgery in one patient at a cost of $445 and TKR surgery
in one patient at a cost of $708. The total cost that could have po-
tentially been avoided for the seven admissions with cancelled sur-
gery was $11 841.
Propensity-weighted regression
Length of stay and costs. Table 2 presents the results from the
weighted regression analyses for LoS and costs. Across all proce-
dures, patients attending the clinic had a significantly longer mean
LoS (9.1 days versus 7.75 days) and significantly higher mean
costs ($22 512 versus $17 210). For the non-cancer procedures,
there were no significant differences in LoS and costs between
the two groups, although the mean differences in LoS and costs
were reduced compared with all procedures. For the cancers, both
CRC and HNC clinic patients had longer LoS and higher costs (
Table 3).
Complications and 12-month mortality. For all procedures
and non-cancer procedures, clinic patients had a higher mean num-
ber of complications although these differences were not
significant (Table 2). By procedure, TURP and CRC had fewer
mean complications in the clinic group compared with control (
Table 3).
The proportion of patients dying within 12months was higher in
the clinic group for all procedures and non-cancer procedures.
Higher proportions of clinic patients died within 12months for
AAA, TURP and THR (Table 3). For the cancer procedures, the
proportion of death within 12months was slightly lower for
HNC and higher for CRC in clinic patients.
Propensity score matching
Length of stay and costs. For all procedures, reducing the cal-
liper width reduced the mean difference in LoS between the clinic
and control groups, but the costs remained significantly higher for
the clinic patients. For the non-cancer procedures, the more restric-
tive calliper resulted in a shorter mean LoS in clinic patients
(Tables 2 and 3). For the cancer procedures, matching reduced
the mean differences in LoS and costs for HNC, but CRC clinic pa-
tients had a significantly longer mean LoS and significantly higher
mean costs (Table 3).
Complications and 12-month mortality. The more restrictive
calliper resulted in lower mean numbers of complications in clinic
patients for the non-cancer procedures and all procedures and the
largest differences in favour of the clinic (Tables 2 and 3).
Results on the proportion of patients dying within 12months for
all procedures and non-cancer procedures were consistent with the
regression results (Table 2). For all procedures, 12 clinic and 8
control patients died with the 0.01 calliper matching, and seven
clinic and four control patients died with the 0.001 calliper
matching.
Supplementary prospective study
Of the 645 questionnaires that were sent to eligible patients, 408
(63%) were returned with 22 only partially completed (some
EQ-5D dimensions were missing responses). Of the 386 (60%)
fully completed questionnaires, 51 (13%) were in the clinic group
and 335 (87%) were in the control group. Total joint replacements
again accounted for the majority (53%) of the selected elective
procedures.
The mean unweighted index score for the clinic group was sig-
nificantly lower than the control group (0.452 versus 0.551, 95%
CI 0.19, 0.01).
Using regression analysis to control for differences in other
baseline characteristics (i.e. the variables included in the retrospec-
tive evaluation), patients attending the clinic had a significantly
lower mean index score than control patients (0.452 versus
0.548, 95% CI 0.188, 0.010) (Table 4), across all procedures.
For the non-cancer procedures, results from the matching were
consistent with the regression findings, with a lower mean index
score in clinic patients. However, the inclusion of cancer proce-
dures (all procedures) resulted in clinic patients reporting higher
mean index scores with the more restrictive calliper. The index
scores by procedure for the matched cohorts are not presented as























Figure 1 Distributions of propensity scores for clinic and control groups
indicating degree of overlap.
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Discussion
This study has reported a mixed retrospective and prospective
evaluation of a new hospital service – a physician-led preoperative
clinic for high-risk patients scheduled for elective surgery. The
aim of the clinic is to optimize medical co-morbidities in patients
in preparation for elective surgery and coordinate postoperative
care. The service was implemented incrementally, without a for-
mal referral pathway or evaluation plan. As the service expanded,
hospital managers requested evidence of the value of the clinic to
support continued investment in the service.
The rationale for a retrospective evaluation of the high-risk
clinic included the availability of a wide range of data sources
and patient-level variables that could be used to control for poten-
tial confounding using appropriate statistical methods; the absence
of a formal referral pathway suggested that not all high-risk pa-
tients would be referred to the clinic (increasing the likelihood of
an appropriate control group for comparison); and the extended
timeframe required to conduct a comprehensive prospective
evaluation.
The results of the retrospective analyses varied according to the
methods used to control for observed potential confounding. The
propensity-weighted regression methods found that patients who
attended the high-risk clinic had increased LoS and costs com-
pared with control patients. Using propensity-based matching, es-
pecially with narrower calliper widths, differences in LoS and
complications were reduced, and in some cases, outcomes were
improved in clinic patients, although costs remained significantly
higher. The high degree of overlap (common support) between
the clinic and control groups (94%) justified the inclusion of
weighting as a potentially valid approach for this comparative
analysis. The subsequent analyses suggested that weighting was
not as robust as the matched analyses but was a relevant option be-
cause of the benefits of maintaining a larger sample size. Matching
on the propensity score closely matched cases and controls in
terms of their baseline characteristics, but the sample sizes were
substantially reduced.
The observed increase in inpatient costs may be partly due to the
labelling effect of the clinic, that is, clinic patients are labelled as
being high risk, which results in additional attention and resource
use over the inpatient episode. Mean 12-month mortality remained
higher in the clinic group in the matched analysis (seven deaths in
the clinic group versus four deaths in the control group). There is
no rationale for a negative clinic effect on 12-month mortality, and
so these results may reflect random variation (the finding was not
statistically significant) or indicate remaining unobserved potential
confounding.
Previous studies of preoperative medical optimization include a
randomized controlled trial that reported a decrease in LoS (0.5-
day decrease, 95% CI 2.0 to 1.1) in patients who received med-
ical preoperative evaluation in an outpatient setting (within
3weeks of surgery) [27]. Other observational studies have re-
ported longer lengths of stay [10,11], higher costs [10] and higher
risks of death at 30 days and 1 year [11] in patients who received
preoperative medical assessment. Auerbach et al. [10] used pro-
pensity scores as weights to adjust for confounding, but the au-
thors indicated that patterns of consultation and other
unmeasured confounding factors in the patient’s medical history
or illness may have biased their results. Further, only the discrim-
inative power of the propensity score model was mentioned and
not whether covariate balance was achieved. Wijeysundera and
colleagues [11] also indicated that their data sources may have
lacked sufficient detail for adequate risk adjustment using propen-
sity score matching.
In this study, we collected a wider range of baseline covariates
than previous observational studies in an attempt to better adjust
for potential confounding factors. We compared alternative pro-
pensity score-based approaches to analysing observational data,
including the recently proposed CBPS methodology. The CBPS
method has been shown to improve the robustness of propensity
Table 4 Differences in health state index scores for unweighted data and after propensity score weighting and matching
Unweighted* Weighted Matched
Health-related quality of life
0.01 calliper 0.001 calliper
Clinic Control n† ATT 95% CI n‡ ATT 95% CI n‡ ATT 95% CI
All procedures 0.452 (0.306) 0.551 (0.315) 382 -0.096 0.188, -0.010 37 -0.042 -0.189, 0.105 19 0.009 -0.202, 0.219
Non-cancer procedures only 0.625 (0.279) 0.735 (0.244) 176 -0.147 -0.302, 0.021 9 -0.086 -0.322, 0.150 3 -0.036 -0.604, 0.532
By procedure
AAA 0.656 (0.417) 0.662 (0.267) 44 -0.062 -0.482, 0.367 — — — —
TURP 0.623 (0.304) 0.757 (0.248) 17 -0.087 -0.544, 0.095 — — — —
TKR 0.570 (0.245) 0.757 (0.209) 43 -0.074 -0.453, 0.043 — — — —
THR 0.655 (0.195) 0.787 (0.231) 72 -0.162 -0.383, 0.120 — — — —
HNC 0.404 (0.203) 0.448 (0.239) 106 -0.070 -0.191, 0.135 — — — —
CRC 0.209 (0.356) 0.328 (0.299) 100 -0.140 -0.388, 0.279 — — — —
Negative ATT values indicate lower health state index scores in clinic patients. Health state index scores for each procedure in the matching cohorts are
not presented as the sample sizes after subgroup analysis are too small.
CBPS, covariate balancing propensity score; ATT, average treatment effect on the treated (calculated as weighted mean outcome for clinic minus
weighted mean outcome for control); 95% CI, 95% confidence interval; AAA, abdominal aortic aneurysm; TURP, transurethral resection of prostate;
TKR, total knee replacement; THR, total hip replacement; HNC, head and neck cancer; CRC, colorectal cancer.
*Reported as mean (standard deviation).
†Total number of patients in the weighted cohort.
‡Number of patients in each group.
C. T. Pham et al.Evaluation of an existing health service
768 © 2016 John Wiley & Sons, Ltd.
76 CHAPTER 5. CLINIC EVALUATION
score models in terms of balancing covariates and reducing bias
[13]. Propensity scores are estimated such that both covariate bal-
ance and prediction of treatment assignment are maximized with
both model fitting and balance checking implemented simulta-
neously [15]. This is an improvement on the existing methods (e.
g. standard logistic regression and boosted logistic regression) that
estimate the probability of treatment assignment and assume auto-
mated covariate balancing. In our study, standard and boosted lo-
gistic regression approaches failed to achieve covariate balance,
whilst the CBPS method achieved balance between a highly com-
plex and sicker patient intervention group and a less complex con-
trol group.
The study design also included a supplementary prospective
survey that collected additional baseline information as patients
were listed for elective surgery, to identify differences between
clinic and non-clinic patients who were not captured by the avail-
able retrospective data. Preoperative quality of life was identified
as a potential unobserved confounder, which has previously been
shown to be significantly associated with postoperative morbidity
and hospital readmission [28] and could provide an early indicator
for patients at risk of complications [29,30] and death [31] after
surgery. To test for the presence of unobserved confounding,
HRQOL data were collected from elective surgery patients pro-
spectively. After adjustment for the covariables included in the ret-
rospective analysis, the weighted analysis showed the clinic group
to have significantly lower mean HRQOL index scores. However,
differences in HRQOL were reduced in the matched analyses, es-
pecially with the more restrictive 0.001 calliper matching. This re-
sult suggests that the retrospective analyses using the 0.001
calliper matching may provide unbiased estimates of the effect
of the clinic. The results from the 0.001 calliper matching showed
positive mean effects on LoS and complications for patients under-
going non-cancer procedures, with statistically significant im-
provements within specific procedure groups.
The prospective data were collected via postal survey, which
may have reduced the sensitivity with which potential confounders
were measured. One such potential confounder is frailty, which
has been shown to be a predictor of surgical morbidity and mortal-
ity and may impact greatly on whether a patient is referred for pre-
operative medical consultation [32–34]. The available data could
inform a frailty index, describing the accumulation of deficits
[35], but data to inform an objective measure of frailty were lack-
ing (e.g. weight loss, exhaustion, weakness, slowness and low
levels of activity) [36].
Other limitations of the analyses include the sample size. Using a
weighted cohort, we were able to preserve the full sample of 121
clinic patients and draw on a control group of 700 patients. How-
ever, given the heterogeneity of the patient population and the treat-
ment effects, and the sensitivity of the weighted estimates to
extreme observations, the number of clinic patients since the incep-
tion of the high-risk clinic may not have been large enough to de-
tect any significant differences. For the more restricted calliper
matching, the sample sizes were substantially reduced as not all
of the clinic patients could be matched to similar control patients.
Clearly, some form of randomized controlled trial is the pre-
ferred study design for the evaluation of such interventions, but
in the absence of resources and buy-in to undertake an experimen-
tal study, can sufficiently robust data be collected and analysed to
overcome the limitations observed in this study?
Further evaluation might be usefully expanded to include hospi-
tals in which the preoperative clinic has not been implemented, in
order to provide greater covariate balance between the intervention
and control groups. The need to collect prospective data precludes
the use of a conventional pretest/posttest study with a contempora-
neous control study design, but procedure-specific differences in
outcomes for cohorts matched to clinic and control patients at
the study hospital could inform an adapted pretest/posttest
approach.
In conclusion, patients referred for preoperative medical optimi-
zation have complex care requirements and are often in poorer
health compared with the general surgical population. The applica-
tion of alternative propensity-based approaches to a large sample
of retrospective data, supplemented with a smaller sample of pro-
spective data, informed a pragmatic approach to reducing potential
observed and unobserved confounding in an evaluation of a
physician-led preoperative clinic. The physician-led high-risk
clinic reduced the frequency of unnecessary admissions and can-
cellations, but significant uncertainty remains around the effect
of the clinic on LoS, complications, costs and post-discharge mor-
tality. This study illustrates the value of mixed retrospective pro-
spective observational study designs but also underlines the need
to prospectively plan for the evaluation of costs and effects along-
side the implementation of significant service innovations.
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5.2.3 Erratum
The authors would like to apologize for the error that was published in the article:
Pham C, Gibb C, Mittinty M, Fitridge R, Marshall V, Karnon J. A Comparison
of Propensity Score Based Approaches to Health Service Evaluation: a Case Study
of a Preoperative Physician-led Clinic for High-Risk Surgical Patients. Journal of
Evaluation in Clinical Practice 2016; 22(5): 761-770.
An error was detected in the code and the number of covariables with standardized
differences of >10% between clinic and control groups for the standard and boosted
logistic regressions is incorrect. The corrected section of this article is printed below:
Page 762, right column, last paragraph, last sentence:
The propensity score models did not improve from standard to boosted. Both ap-
proaches failed to achieve covariate balance with standardized differences of >10%
between the clinic and control groups for 2 and 13 covariables in the standard and
boosted logistic regressions, respectively. Given that the aim of boosted logistic
regression is to minimize the prediction error, the increase in the number of un-
balanced covariables suggested that this approach was inappropriate for confounder
adjustment in this dataset (Friedman 2001).
Friedman JH. Greedy function approximation: a gradient boosting machine. Annals
of Statistics 2001; 29(5): 1189-1232.
5.3 Data sources
5.3.1 Preoperative Assessment Patient Questionnaire
A retrospective casenote review was conducted to collect additional co-morbidity
data on the control patients to match the level of detail recorded in the clinic data-
base on clinic patients. All patients scheduled for elective surgery at the Royal Ad-
elaide Hospital receive a booking pack containing forms that must be completed and
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returned, one of which is a preoperative assessment patient questionnaire (PAPQ)
(Figure 5.1). Additional information on the patient’s health status, existing condi-
tion(s) and current medication(s) are collected via this questionnaire that is placed
in the patient’s medical records as a reference but the data is not entered into the
electronic database. Data from the PAPQ were manually extracted from medical
case records within the medical records department at the Royal Adelaide Hospital.
5.3.2 Surgical severity
The Johns Hopkins Surgical Risk Classification System (JHSRCS) was used as an
indicator of surgical severity, a covariable in the propensity score estimation, for
the range of elective surgical procedures included in the analysis (Table 5.1). This
classification system is based on a combination of factors that contribute to the risk
of surgery, including invasiveness, associated blood loss and fluid shift, entry into
specific body areas (e.g. intrathoracic and intracranial), postoperative anatomic and
physiologic alterations, and the need for postoperative intensive care monitoring.
5.3.3 Health-related quality of life
Health-related quality of life (HRQOL) data was collected using the EuroQOL five-
dimension questionnaire (EQ-5D) (EuroQol Group 1990). The EQ-5D-5L is the
updated version of the EQ-5D, one of the most widely used health status instru-
ments, and comprises five questions, each with five levels, representing five health
domains: pain, mood, mobility, self-care and daily activities (Herdman et al. 2011).
Further detailed questions on the patient’s medical co-morbidities were included in
the additional questionnaire to determine whether additional information on the
severity of such co-morbidities could improve the characterisation of clinic patients.
Figure 5.2 details the research questionnaire that was sent to patients for completion.
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Figure 5.1: The Preoperative Assessment Patient Questionnaire.
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Table 5.1: Johns Hopkins Surgical Risk Classification System (JHSRCS).
JHSRCS
status





with minimal blood loss






Procedures limited in their
nature, usually with
minimal to mild blood loss
and only mild associated
risk to the patient
independent of medical
conditions and anaesthesia
Transurethral resection of prostate
Endovascular/endoluminal AAA
repair (Vascular)
Panendoscopy + biopsy (HNC)
Parotidectomy (HNC)







moderate blood loss with














Laparoscopic assisted loop ileostomy
(CRC)
Open hemicolectomy (CRC)













Open AAA repair (Vascular)
AAA, abdominal aortic aneurysm; CRC, colorectal cancer surgery; HNC, head and
neck cancer surgery.
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Figure 5.2: The EQ-5D 5 level version (EQ-5D-5L) and additional questions on
the patient’s medical co-morbidities.
     
Version 2.0  3 July 2012  PLEASE TURN OVER 
Surname: __________________________________  
Given Names:  ______________________________  
Date of Birth:  _______________________________  
RESEARCH QUESTIONNAIRE 
Under each heading, please tick the ONE box that best describes your health TODAY: 
1. MOBILITY 
 I have no problems in walking about 
 I have slight problems in walking about 
 I have moderate problems in walking about 
 I have severe problems in walking about 
 I am unable to walk about 
2. SELF-CARE 
 I have no problems washing or dressing myself 
 I have slight problems washing or dressing myself 
 I have moderate problems washing or dressing myself 
 I have severe problems washing or dressing myself 
 I am unable to wash or dress myself 
3. USUAL ACTIVITIES (e.g. work, study, housework, family or leisure activities) 
 I have no problems doing my usual activities 
 I have slight problems doing my usual activities 
 I have moderate problems doing my usual activities 
 I have severe problems doing my usual activities 
 I am unable to do my usual activities 
4. PAIN / DISCOMFORT 
 I have no pain or discomfort 
 I have slight pain or discomfort 
 I have moderate pain or discomfort 
 I have severe pain or discomfort 
 I have extreme pain or discomfort 
5. ANXIETY / DEPRESSION 
 I am not anxious or depressed 
 I am slightly anxious or depressed 
 I am moderately anxious or depressed 
 I am severely anxious or depressed 
 I am extremely anxious or depressed 
We may be asking you the above questions again in 6 and 12 months to see if your quality of life has 
improved.  
Please provide your telephone number:  (             )    .........................................  
 I do not wish to be contacted at 6 and 12 months  
 
Version 2.0  3 July 2012  PLEASE TURN OVER 
RESEARCH QUESTIONNAIRE 
PLEASE TICK RELEVANT BOX AND ANSWER ALL QUESTIONS  
YES NO 
  Do you have a regular GP you go to? Details:  ................................................................................ 
  How often do you see your GP?  .................................................................................................... 
  Have you ever had high cholesterol? Details:  ................................................................................ 
  Have you ever had a blood clot in your legs or lungs? When? ........................................................ 
  Did you need warfarin? Details:  .................................................................................................... 
  Do you have difficulty breathing when you lie flat? Details:  .......................................................... 
  How many pillows do you sleep on?  .............................................................................................. 
  Does your breathing ever wake you up when you are sleeping? Details:  ...................................... 
  Have you ever been told you have dementia? Details:  .................................................................. 
  Do you have concerns about your memory?  ................................................................................. 
  Has anyone else been concerned about your memory? Details: .................................................... 
  Have you ever had heart failure or fluid build up in your lungs? Details:  ...................................... 
  Did you need to go to hospital because of fluid? ........................................................................... 
  Do you have problems eating because of your teeth?  ................................................................... 
  Have you had a blood transfusion in the last 6 months? Details:  .................................................. 
  Have you had iron tablets in the last 12 months? Details:  ............................................................ 
  If you have diabetes, is your doctor happy with your blood sugar control?  ................................... 
   Have you had a stroke(s)? If yes, did it affect your arms  legs  speech  vision ?  
 Before your stroke(s), were you right-handed  or left-handed ? Details:  ....................................... 
 Did the stroke(s) affect the right-side  or left-side  of your body? Details:  ..................................... 
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5.4 Propensity score methodology
Propensity score estimation using the standard logistic regression and boosted lo-
gistic regression were tested prior to the CBPS method in the final analysis. The
standard logistic regression and boosted logistic regression are based on two mo-
ments (mean and variance) and assumes automated covariate balancing (Wyss et al.
2014). The CBPS method, a doubly robust approach, differs from and outperforms
the standard regression methods (using generalized linear models with maximum
likelihood estimation) by using a generalized method of moments framework that
uses the entire distribution of baseline covariates; an important factor when dealing
with skewed data (as was the case with this dataset) (Imai and Ratkovic 2014).
The two standard regression methods failed to achieve covariate balance, the
results of which are documented below.
5.4.1 Standard logistic regression
For standard logistic regression, the ‘glm’ command and the ‘logit’ link function
were used in R statistical programming language (R Core Team 2013).
Table 5.2 details the characteristics of the clinic and control patients pre-propensity
and post-propensity score weighting using standard logistic regression for propensity
score estimation. The percentage of overlap between the clinic and control propensity
score distribution was 97% (Figure 5.3) and the variance ratios were <2.0 for all 24
covariables after weighting. However, this method failed to achieve covariate bal-
ance with standardised differences of >10% between the clinic and control patients
for SEIFA score and smoking status after propensity score weighting.
5.4.2 Boosted logistic regression
For the generalised boosted regression, the ‘twang’ package (Ridgeway et al. 2013)
was used in R statistical programming language (R Core Team 2013).
Table 5.3 details the characteristics of the control and clinic patients pre-propensity
and post-propensity score weighting using boosted logistic regression for propensity
score estimation. This method failed to achieve covariate balance with standard-
ised differences of >10% between the clinic and control patients for SEIFA score,
BMI, marital status, ischaemic heart disease, congestive heart failure, stroke, renal
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Table 5.2: Patient characteristics and balance diagnostics using standard logistic
regression for propensity score estimation.
Unweighted Propensity weighted
Characteristic Clinic Control Standardised Variance P-value Control Standardised Variance P-value
(n=121) (n=700) difference ratio difference ratio
Age (mean years) 73.6 69.2 0.47 0.75 0.00 73.6 0.00 0.94 1.00
Female 37.2 38.4 −0.03 0.99 0.80 37.3 −0.00 1.01 0.99
Surgical procedure 0.98 0.69 1.01 0.99
Abdominal aortic aneurysm 7.4 9.1 −0.07 0.83 0.54 7.6 −0.01 0.99 0.96
Transurethral resection of prostate 9.1 8.9 0.01 1.03 0.93 10.5 −0.05 0.89 0.73
Total knee replacement 22.3 22.7 −0.01 0.99 0.92 19.5 0.07 1.11 0.54
Total hip replacement 22.3 27.0 −0.11 0.89 0.28 20.8 0.04 1.06 0.74
Head and neck cancer surgery 16.5 12.0 0.12 1.32 0.17 17.4 −0.02 0.97 0.85
Colorectal cancer surgery 22.3 20.3 0.05 1.08 0.61 24.3 −0.05 0.95 0.72
Surgical severity 0.98 0.79 0.92 0.76
Mild 20.7 19.1 0.04 1.07 0.70 24.6 −0.10 0.89 0.47
Moderate 76.9 77.3 −0.01 1.02 0.92 73.3 0.08 0.92 0.52
Significant 2.5 3.6 −0.07 0.71 0.54 2.1 0.02 1.18 0.80
Urgency category 0.95 0.35 1.01 0.99
Within 30 days 48.8 44.3 0.09 1.02 0.36 48.1 0.01 1.01 0.92
Within 90 days 18.2 15.7 0.06 1.13 0.50 18.4 −0.01 1.00 0.96
Within 1 year 33.1 40.0 −0.15 0.93 0.15 33.5 −0.01 1.00 0.95
SEIFA (mean score) 959.7 968.0 −0.12 0.84 0.22 966.8 −0.10 0.77 0.42
BMI (mean score) 29.5 28.5 0.16 1.15 0.11 29.2 0.06 0.81 0.64
Smoking status 0.96 0.85 1.12 0.64
Never 39.7 38.1 0.03 1.02 0.75 36.3 0.07 1.04 0.56
Former 48.8 48.4 0.01 1.01 0.95 54.1 −0.11 1.01 0.38
Current 11.6 13.4 −0.06 0.89 0.58 9.6 0.06 1.18 0.55
Marital status 1.11 0.18 1.05 0.96
Never married 10.7 11.1 −0.01 0.98 0.90 8.4 0.08 1.26 0.45
Married/De facto 51.2 60.1 −0.18 1.05 0.07 51.7 −0.01 1.01 0.94
Widowed 19.0 15.1 0.10 1.21 0.28 20.5 −0.04 0.95 0.77
Divorced 16.5 10.1 0.17 1.52 0.04 17.1 −0.02 0.98 0.91
Separated 2.5 3.4 −0.06 0.74 0.59 2.4 0.01 1.04 0.96
Medical co-morbidities
Ischaemic heart disease 66.1 32.0 0.72 1.04 0.00 66.3 0.00 1.01 0.98
Congestive heart failure 5.0 0.7 0.20 6.69 0.03 7.0 −0.09 0.73 0.65
Stroke 19.0 6.0 0.33 2.75 0.00 21.2 −0.06 0.93 0.71
Diabetes mellitus 33.1 20.1 0.27 1.39 0.01 34.0 −0.02 0.99 0.87
Renal impairment 34.7 16.7 0.38 1.64 0.00 35.6 −0.02 1.00 0.89
Anaemia 40.5 26.4 0.29 1.25 0.00 44.0 −0.07 0.98 0.57
Dementia including Alzheimer’s 3.3 0.6 0.15 5.66 0.10 1.8 0.08 1.83 0.46
Asthma/COPD 44.6 30.6 0.28 1.17 0.00 44.3 0.01 1.01 0.96
Hypertension 16.5 7.1 0.25 2.09 0.01 14.7 0.05 1.11 0.70
Fall in previous 12 months 5.8 2.3 0.15 2.46 0.11 4.4 0.06 1.31 0.60
Able to walk around house 57.9 70.0 −0.25 1.17 0.01 58.5 −0.01 1.01 0.92
Able to walk upstairs 37.2 50.9 −0.28 0.94 0.00 37.5 −0.01 1.00 0.97
Physical disabilities 38.8 25.4 0.27 1.26 0.01 41.0 −0.04 0.99 0.73
Artificial joints/implants 20.7 25.6 −0.12 0.87 0.22 19.1 0.04 1.07 0.74
Days since clinic was established (mean)* 1127.9 1048.3 0.25 0.82 0.01 1130.8 −0.01 0.76 0.95























Figure 5.3: Distributions of propensity scores with standard logistic regression for
clinic and control groups indicating degree of overlap.
impairment, dementia including Alzheimer’s disease, hypertension, fall in the previ-
ous 12 months, able to walk around the house, able to walk upstairs, and physical
disabilities after propensity score weighting. Congestive heart failure and dementia
including Alzheimer’s disease had variance ratios of >2.0 after weighting.
The percentage of overlap between the clinic and control propensity score distri-
bution was 57% (Figure 5.4).
Additional comments from the reviewer suggested three other methods for ad-
dressing the imbalance between treatment and control groups: stratification/ sub-
classification, coarsened exact matching, and the doubly robust estimator introduced
by Robins (2000). Responses to these suggestions are detailed below.
• Due to the high degree of overlap with the covariate balancing propensity score
(CBPS) method, stratification/subclassification was not considered. The au-
thors are satisfied with the CBPS method, which generates propensity score
estimates by selecting parameter values that maximise the resulting covari-
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Table 5.3: Patient characteristics and balance diagnostics using boosted logistic
regression for propensity score estimation.
Unweighted Propensity weighted
Characteristic Clinic Control Standardised Variance P-value Control Standardised Variance P-value
(n=121) (n=700) difference ratio difference ratio
Age (mean years) 73.6 69.2 0.47 0.75 0.00 73.0 0.07 0.96 0.53
Female 37.2 38.4 −0.03 0.99 0.80 38.1 −0.02 1.00 0.86
Surgical procedure 0.98 0.69 0.97 0.96
Abdominal aortic aneurysm 7.4 9.1 −0.07 0.83 0.54 8.6 −0.04 0.88 0.69
Transurethral resection of prostate 9.1 8.9 0.01 1.03 0.93 10.1 −0.03 0.92 0.76
Total knee replacement 22.3 22.7 −0.01 0.99 0.92 21.5 0.02 1.04 0.85
Total hip replacement 22.3 27.0 −0.11 0.89 0.28 25.1 −0.07 0.93 0.56
Head and neck cancer surgery 16.5 12.0 0.12 1.32 0.17 13.4 0.08 1.20 0.43
Colorectal cancer surgery 22.3 20.3 0.05 1.08 0.61 21.4 0.02 1.04 0.84
Surgical severity 0.98 0.79 0.89 0.75
Mild 20.7 19.1 0.04 1.07 0.70 22.2 −0.04 0.95 0.73
Moderate 76.9 77.3 −0.01 1.02 0.92 74.1 0.07 0.93 0.56
Significant 2.5 3.6 −0.07 0.71 0.54 3.7 −0.08 0.68 0.53
Urgency category 0.95 0.35 0.99 0.81
Within 30 days 48.8 44.3 0.09 1.02 0.36 45.8 0.06 1.01 0.58
Within 90 days 18.2 15.7 0.06 1.13 0.50 18.0 0.00 1.01 0.98
Within 1 year 33.1 40.0 −0.15 0.93 0.15 36.2 −0.07 0.97 0.54
SEIFA (mean score) 959.7 968.0 −0.12 0.84 0.22 968.9 −0.14 0.94 0.22
BMI (mean score) 29.5 28.5 0.16 1.15 0.11 28.8 0.12 1.03 0.27
Smoking status 0.96 0.85 1.10 0.76
Never 39.7 38.1 0.03 1.02 0.75 38.2 0.03 1.02 0.78
Former 48.8 48.4 0.01 1.01 0.95 52.1 −0.07 1.01 0.54
Current 11.6 13.4 −0.06 0.89 0.58 9.7 0.06 1.17 0.55
Marital status 1.11 0.18 1.23 0.50
Never married 10.7 11.1 −0.01 0.98 0.90 7.8 0.10 1.34 0.31
Married/De facto 51.2 60.1 −0.18 1.05 0.07 58.5 −0.15 1.04 0.18
Widowed 19.0 15.1 0.10 1.21 0.28 19.7 −0.02 0.98 0.87
Divorced 16.5 10.1 0.17 1.52 0.04 11.6 0.13 1.35 0.17
Separated 2.5 3.4 −0.06 0.74 0.59 2.3 0.01 1.07 0.92
Medical co-morbidities
Ischaemic heart disease 66.1 32.0 0.72 1.04 0.00 57.1 0.19 0.92 0.08
Congestive heart failure 5.0 0.7 0.20 6.69 0.03 2.0 0.14 2.42 0.19
Stroke 19.0 6.0 0.33 2.75 0.00 14.0 0.13 1.29 0.25
Diabetes mellitus 33.1 20.1 0.27 1.39 0.01 29.5 0.08 1.07 0.50
Renal impairment 34.7 16.7 0.38 1.64 0.00 28.1 0.14 1.13 0.22
Anaemia 40.5 26.4 0.29 1.25 0.00 39.1 0.03 1.02 0.79
Dementia including Alzheimer’s 3.3 0.6 0.15 5.66 0.10 0.5 0.16 6.56 0.09
Asthma/COPD 44.6 30.6 0.28 1.17 0.00 40.5 0.08 1.03 0.45
Hypertension 16.5 7.1 0.25 2.09 0.01 10.9 0.15 1.43 0.19
Fall in previous 12 months 5.8 2.3 0.15 2.46 0.11 3.0 0.12 1.90 0.22
Able to walk around house 57.9 70.0 −0.25 1.17 0.01 65.0 −0.14 1.08 0.19
Able to walk upstairs 37.2 50.9 −0.28 0.94 0.00 42.5 −0.11 0.96 0.31
Physical disabilities 38.8 25.4 0.27 1.26 0.01 30.8 0.16 1.12 0.13
Artificial joints/implants 20.7 25.6 −0.12 0.87 0.22 20.5 0.00 1.01 0.97
Days since clinic was established (mean)* 1127.9 1048.3 0.25 0.82 0.01 1098.9 0.09 1.03 0.39























Figure 5.4: Distributions of propensity scores with boosted logistic regression for
clinic and control groups indicating degree of overlap.
ate balance, regardless of modelling assumptions. This minimises the poten-
tial misspecification of a parametric propensity score model, a common issue
with other propensity score estimation methods. Previous analyses have also
suggested that propensity score matching is more effective at dealing with
systematic differences in baseline characteristics between treatment and con-
trol subjects than stratification on the propensity score (Austin and Mamdani
2006, Austin et al. 2007, Austin 2009).
• Coarsened exact matching (CEM) aims to reduce the imbalance between treat-
ment and control groups without estimating the propensity score (King et al.
2011). CEM assigns a level of imbalance ex ante and then fixes any resid-
ual imbalances by temporarily coarsening each covariable (King et al. 2011).
The authors’ aim was to achieve balance between the treatment and control
groups to improve the propensity score estimation for use in the outcome mod-
els. Thus, the CBPS method was used as it enables the robust and efficient
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estimation of the propensity score by directly incorporating the key covariate
balancing property of the propensity score (Imai and Ratkovic 2014).
• Kang and Schafer (2007) tested the doubly robust estimator of Robins (2000)
and found that it provided a consistent estimate of the treatment effect as long
as the outcome model or the propensity score model was correct. However,
when both models were slightly misspecified, the performance of the doubly
robust estimator deteriorated. The CBPS estimation method can yield robust
estimates of treatment effects, even when both the outcome and propensity
score models are misspecified (Imai and Ratkovic 2014). Imai and Ratkovic
(2014) reported that the CBPS achieved better covariate balance than the
standard logistic regression method when both the outcome and propensity
score models were correctly specified, and when both models are misspecified,
the CBPS improved the covariate balance with some loss of likelihood.
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One of the main goals of elective surgery is to improve health-related quality of life
(QoL) for the patient. However, QoL outcome measures, commonly used to inform
the estimation of quality adjusted life years (QALYs) in cost-effectiveness analyses,
are not currently routinely collected within the study hospital.
In cancer patients, patient-reported preoperative QoL scores have been used as
predictors of postoperative complications (Bingener et al. 2015, Doll et al. 2014), hos-
pital readmission (Doll et al. 2014) and overall survival (Sloan et al. 2012, Von Gru-
enigen et al. 2012, Velanovich 2011).
This study is an extension of the supplementary prospective study exploring
quality of life as a potentially unmeasured confounder, as part of an evaluation of
the high-risk clinic (see Chapter 5.2). Preoperative QoL, measured at the time
the patient was placed on the surgery waiting list, was identified as a potential
unmeasured confounder with the clinic group reporting significantly lower mean QoL
index scores than the control group (Pham et al. 2016). QoL data has the potential
to improve the characterisation of complex patients referred to the high-risk clinic
and could be an early indicator of operative risk and postoperative morbidity and
mortality.
The aims of this study were to determine whether health-related QoL was an
additional indicator of high risk in a patient, and compare changes in QoL before
and after surgery in patients attending and not attending the high-risk clinic.
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6.2 Methods
6.2.1 Patient recruitment
Prospective patients listed for elective surgery between June 2012 and October 2013
at the RAH were identified via hospital elective surgery waiting lists. Identified
patients were eligible if they were aged 18 years and over and listed for at least one
of the following selected elective surgical procedures: transurethral resection of the
prostate, total hip or knee replacement, abdominal aortic aneurysm repair, head
and neck cancer surgery and colorectal cancer surgery.
Patients were originally recruited via an opt-in strategy, with an information
sheet and questionnaire added to the elective surgical admission booking pack (con-
taining standard RAH forms that all patients must complete in order to proceed to
surgery). It was anticipated that patients would complete the questionnaire while
in the waiting room of the outpatient clinic but the response rate using this strategy
was very poor with only two of the 39 eligible patients returning the baseline ques-
tionnaire. The distribution of the questionnaire was then changed to target eligible
patients with a personalised letter, sent via postal mail, inviting them to participate
in the study. Questionnaires were sent to patients attending and not attending the
high-risk clinic.
Patients were referred to the high-risk clinic (‘clinic’) at the discretion of the
surgical consultant or anaesthetist around the time of the decision to undergo sur-
gery. Patients who were not referred to the clinic (‘control’) either proceeded to
surgery without further sub-specialist consultation or were referred, at the surgical
consultant’s discretion, to a sub-specialist for management of a specific condition
(e.g. cardiologist, nephrologist).
6.2.2 Data collection
Eligible patients were asked to complete the EuroQOL five dimension questionnaire
(EQ-5D) (EuroQol Group 1990) and a set of additional co-morbidity questions at
baseline (see Chapter 5.3.3). Patients who completed the baseline questionnaire and
did not opt-out of recontact were asked to complete the EQ-5D questionnaire again
at six and 12 months.
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The EQ-5D-5L was chosen as it gives more weight to physical functioning, as
opposed to the social functioning in the SF-6D (van Stel and Buskens 2006). The
physical functioning component was considered to be more relevant than the social
functioning in this study, as the high-risk clinic intervention has a greater focus on
managing the physical aspects of the patient.
Data from the patient-completed PAPQ (see Chapter 5.3.1) were extracted from
the elective surgical admission booking packs via weekly visits to the surgical units at
the RAH. Detailed patient and clinical information, including the hospital admission
for the selected surgical procedure and whether the patient was referred to the high-
risk clinic, were extracted from the hospital database.
In circumstances where a patient ticked ‘I am extremely anxious or depressed’
in the EQ-5D-5L, the researcher informed the Consultant Physician involved in the
study who sent a letter to the patient with recommendations to seek further help
and a Beyond Blue pamphlet.
6.2.3 Statistical analyses
The CBPS estimation method, as described in Pham et al. (2016) (see Chapter 5.2),
was used for propensity score estimation to adjust for potential observed confounding
and balance selected patient characteristics across treatment groups. Covariables
that could potentially influence whether a patient was referred to the clinic were
selected a priori and were based on the covariables used in the previous analysis
(Pham et al. 2016) (see Chapter 5.2). Covariables included patient demographics,
surgery-related factors, patient’s physical function and nine medical co-morbidities
targeted by the high-risk clinic with the greatest potential to be modified: ischaemic
heart disease, congestive heart failure, stroke, diabetes mellitus, renal impairment,
anaemia, dementia including Alzheimer’s disease, asthma or chronic obstructive
pulmonary disease, and primary hypertension. Table 6.1 details the characteristics
of the control and clinic patients pre-propensity and post-propensity score weighting.
Due to the small sample size, the CBPS estimation method was unable to balance
all 19 covariables, with standardised differences of >10% between clinic and control
groups remaining in six of the covariables.
Regression using generalised linear modelling was used to test the association
between health state index scores and clinic patients before and after surgery. The
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six covariables with standardised differences of >10% were included as independent
variables in the regression model. Non-parametric bootstrapping (1,000 iterations)
was then applied to estimate the 95% CI. Results are presented as means or mean
differences with 95% CI. Negative mean differences indicate lower health state index
scores in clinic patients. The CBPS estimation method using the ‘CBPS’ package
(Ratkovic and Imai 2014), regression analyses and bootstrapping were performed
using R statistical programming language (R Core Team 2013).
Analyses of health state index scores before and after surgery for clinic and
control patients were performed due to the variation in the timing of responses to
the EQ-5D. The timing of surgery was dependent on the type and urgency of the
surgical procedure and the length of the waiting list, so for patients who completed
the EQ-5D at all three time points, surgery could have occurred between baseline
and six months or between six and 12 months. For such cases, the first EQ-5D
measured after surgery was used in the analysis. Patients who only completed the
EQ-5D at one follow-up time point, either six or 12 months, and had surgery between
baseline and follow-up were included in the before and after analyses.
The EQ-5D profiles were transformed, using the value set for the United King-
dom1, into weighted health state index scores, ranging from -0.594 (worst health
state) to 1.00 (best health state) (EuroQol Group 2012). When interpreting the
impact of changes in the index scores, a minimally important difference value of
0.074 was used (Walters and Brazier 2005). In order to detect a 0.074 difference in
index scores at 80% power and a significance level of 0.05, 244 patients were needed
in each treatment group.
Ethics approval was granted by the South Australian Department of Health Hu-
man Research Ethics Committee (HREC Protocol No. 490/01/2015) and the Royal
Adelaide Hospital Research Ethics Committee (RAH Approval No. 120225/120225a).
6.3 Results
Of the 645 eligible patients who were sent questionnaires, 386 (60%) returned com-
pleted baseline questionnaires (Figure 6.1). Of the 386 patients with a baseline
EQ-5D measure, 183 (47%) were included in the before and after analyses with 131
1an EQ-5D value set for Australia is not yet available
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patients completing the EQ-5D at all 3 time points and 52 patients either complet-
ing the baseline and 6-month EQ-5D (26 patients) or the baseline and 12-month
EQ-5D (26 patients). Patients were mainly excluded from the analyses if they did
not wish to be recontacted or if they had their surgical procedure, predominantly
for head and neck cancer and abdominal aortic aneurysm repair, before returning
their baseline EQ-5D measure (Figure 6.1).




n = 386 (60%)
51 clinic, 335 control
235 (37%) did not return questionnaires
22 (3%) returned incomplete questionnaires
2 (0.3%) returned blank questionnaires
Completed 12-month QoL
n = 26 (4%)
4 clinic, 22 control
Completed 6-month QoL
n = 26 (4%)
4 clinic, 22 control
Completed 6-month QoL
n = 131 (20%)
12 clinic, 119 control
Completed 12-month QoL
n = 131 (20%)
12 clinic, 119 control
95 (15%) had surgery before baseline
51 (8%) did not wish to be recontacted
23 (4%) returned incomplete questionnaires
18 (3%) did not have surgery
10 (2%) had surgery after 12-month follow-up
6 (0.9%) not followed up (patient died)
Figure 6.1: Flowchart of patient recruitment. The number of patients lost to
follow-up and the reasons for exclusion could occur anywhere between the baseline
and 12-month questionnaires (area shaded in blue).
Table 6.1 details the characteristics of the 163 control and 20 clinic patients pre-
propensity and post-propensity score weighting. Total joint replacements accounted
for the majority (65%) of the selected surgical procedures. Compared with control
patients, clinic patients tended to be older, female, have modifiable co-morbidities
targeted by the clinic and physical disabilities. Fewer clinic patients were able to
walk around the house and/or upstairs.
The mean unweighted index scores for the clinic group was significantly lower
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Table 6.1: Patient characteristics and balance diagnostics for quality of life data.
Unweighted Propensity weighted
Characteristic Clinic Control Standardised Control Standardised
(n=20) (n=163) difference difference
Age (mean years) 75.6 69.4 0.78 74.2 0.12
Female 63.2 50.3 0.13 56.2 0.04
Surgical procedure
Abdominal aortic aneurysm 5.3 2.8 0.03 5.7 −0.01
Transurethral resection of prostate 0.0 10.3 −0.10 0.0 0.00
Total knee replacement 47.4 31.7 0.16 39.4 0.11
Total hip replacement 36.8 36.6 0.00 44.8 −0.09
Head and neck cancer surgery 0.0 0.7 −0.01 0.0 0.00
Colorectal cancer surgery 10.5 17.9 −0.07 10.1 −0.01
Urgency category
Within 30 days 21.1 11.0 0.10 15.8 0.04
Within 90 days 0.0 17.9 −0.18 0.0 0.00
Within 1 year 78.9 62.8 0.16 84.2 −0.04
Deferred 0.0 8.3 −0.08 0.0 0.00
BMI (mean score) 29.2 30.0 −0.16 29.0 0.06
Smoking status
Never 31.6 42.8 −0.11 14.2 0.17
Former 57.9 50.3 0.08 74.7 −0.16
Current 10.5 6.9 0.04 11.1 −0.01
Medical co-morbidities
Ischaemic heart disease 73.7 24.1 0.50 62.8 0.11
Congestive heart failure 31.6 10.3 0.21 28.1 0.02
Stroke 10.5 3.4 0.07 8.3 0.03
Diabetes mellitus 31.6 13.1 0.18 20.4 0.12
Renal impairment 5.3 3.4 0.02 8.3 −0.03
Anaemia 36.8 16.6 0.20 20.9 0.16
Dementia including Alzheimer’s 15.8 22.1 −0.06 19.9 −0.04
Asthma/COPD 36.8 30.3 0.07 37.2 −0.02
Hypertension 84.2 58.6 0.26 91.3 −0.05
Able to walk around house 36.8 62.1 −0.25 47.7 −0.09
Able to walk upstairs 21.1 35.2 −0.14 22.3 −0.02
Physical disabilities 42.1 24.1 0.18 37.2 0.07
Artificial joints/implants 31.6 28.3 0.03 32.6 0.00
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than the control group before surgery (0.371 versus 0.515, mean difference -0.144,
95% CI -0.287, -0.001) with a smaller difference in unweighted index scores after
surgery (0.597 versus 0.696, mean difference -0.099, 95% CI -0.213, 0.015).
After weighting, there were no significant differences in the mean index scores
between the clinic and control groups before surgery (weighted mean difference
-0.059, 95% CI -0.151, 0.100) and after surgery (weighted mean difference -0.083,
95% CI -0.196, 0.082) (Figure 6.2). Both groups reported higher mean index scores
(improved quality of life) after surgery. There were also no significant differences
in the magnitude of quality of life improvement for the clinic and control groups
(weighted mean difference -0.028, 95% CI -0.203, 0.146). Of the 163 control pa-
tients, 91 (56%) had an improvement of at least 0.074 in their EQ-5D score after
surgery, 23 (14%) reported a deterioration of greater than 0.074 in their EQ-5D
score, and 49 (30%) reported no or small changes in their EQ-5D score. Of the 20
clinic patients, 12 reported an improvement of at least 0.074, 5 reported a deteri-
oration of greater than 0.074, and 3 reported no or small changes in their EQ-5D
score after surgery.
6.4 Discussion
Due to the small sample of usable preoperative and postoperative QoL measures, it
was not possible to draw any meaningful conclusions from the data.
The available data suggests that clinic patients have a lower mean preoperative
QoL index score than control patients and similar magnitudes of improvement in
QoL in each group after surgery. The lower mean preoperative and postoperat-
ive index scores in clinic patients compared with control remained after weighting,
suggesting that QoL could potentially be an additional indicator of high risk in a
patient.
The CBPS method for propensity score estimation was unable to balance 6 of the
19 covariables indicating that the control group in this sample could not be matched
(at the group level) to the complex, high-risk clinic group. A mean preoperative QoL
index score of 0.371 in clinic patients is among the lowest reported in the published
literature, with similar mean preoperative EQ-5D index scores reported in lumbar
spinal stenosis patients (0.36) (Jansson et al. 2009) and in people with depression
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Figure 6.2: EQ-5D index scores before and after surgery for the clinic group and
unweighted and weighted control group.
(0.38) (Burström et al. 2001). The mean preoperative QoL index score in the control
patients of 0.431 is similar to QoL index scores of stroke patients (0.44) (Burström
et al. 2001). The lower mean preoperative QoL index score in clinic patients suggests
that preoperative QoL could improve the characterisation of clinic patients.
In this small sample of patients, we found that health-related quality of life
improves after elective surgery in both clinic and control patients. Further research
should focus on identifying an appropriate control group, with the potential use of
the preoperative QoL index score, to match the highly complex and sicker clinic
patient subset. In this study, there were difficulties with identifying a relevant,
contemporary control group in the hospital that established the high-risk clinic.
Patients managed in other similar hospitals could be used as a control group but
the differences in clinical pathways and care delivery models may affect QoL and
must be considered. Given the challenges with using an observational dataset on
this cohort of complex patients, a full cost-effectiveness analysis was considered to be
of limited value. A qualitative component focusing on the validation of the findings
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from this quantitative evaluation was deemed to be of greater value and is detailed
in the following chapter (Chapter 7).
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Chapter 7
Assessing the validity of the
evaluation findings
7.1 Preface
This chapter presents the qualitative component undertaken to assess the validity
of the findings from the quantitative evaluation of the clinic in Chapter 5. This
explanatory study explores the reasons for and expectations of referral to the high-
risk clinic, validates the baseline covariates used in the evaluation, assesses the
potential for unmeasured confounding, and assesses whether the value of the high-
risk clinic was appropriately captured in the outcomes used in the evaluation.
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Patients with co-morbidities can be referred to a physician-led high-risk clinic prior
to elective surgery at the discretion of the surgical consultant, but the factors that
influence this referral are not well understood. The aims of this study were to
understand the factors that influence a surgeon’s decision to refer a patient to the
clinic, and how the clinic impacts on the management of complex patients.
Methods
Theoretical thematic analysis was used to analyze transcribed semi-structured in-
terviews with seven surgical consultants who were eligible to refer patients to the
clinic.
Results
When discussing the factors that influence a referral to the clinic, all participants
initially described the optimization of co-morbidities and would then discuss with
examples the challenges with managing complex patients and communicating the
risks involved with having surgery. When discussing the role of the clinic, two
related sub-themes were dominant and focused on the management of risk in complex
patients. The participants valued the involvement of the clinic in the decision-
making and communication of risks to the patient.
Conclusions
The integration of the high-risk clinic in this study appears to offer additional value
in supporting the decision-making process for the surgical team and patient beyond
the clinical outcomes. The factors that influence a surgeon’s decision to refer a
patient to the clinic appear to be driven by the aim to manage the uncertainty and
risk to the patient regarding surgery and it was seen as a strategy for managing
difficult and complex cases. Further research is required to explore the perspectives
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of the patient and other medical professionals collaborating with the clinic and guide
the optimal use of the high-risk clinic.
7.3.2 Introduction
The decision of whether to operate on a patient can be complex. For patients who
are young and fit with no other medical co-morbidities, the decision to proceed
with surgery is relatively straight-forward. In contrast, the decision to operate on a
patient who is frail and/or has multiple medical co-morbidities can be challenging,
and could potentially involve a large degree of uncertainty due to the increased risk
of morbidity and mortality during the perioperative period (Kuwabara et al. 2008,
Librero et al. 1999).
A set of potentially modifiable co-morbidities have been identified to be associ-
ated with increased length of hospital stay and postoperative complications (Pham
et al. 2014). Patients with poorly controlled modifiable co-morbidities can be re-
ferred for medical optimization prior to elective surgery at the discretion of the
surgical consultant, but the factors that influence this referral are not well under-
stood (Pham et al. 2017). Further, there has been minimal detail published on
the actual services provided as part of the medical optimization of patients and its
design and implementation has been heterogeneous to date (Pham et al. 2017).
The number of patients with multiple co-morbidities increases with an aging
population. Outpatient clinics, such as the Perioperative High Risk Clinic at the
Royal Adelaide Hospital in South Australia, have been established to co-manage
complex patients by targeting, managing and optimizing their modifiable medical
co-morbidities. A recent evaluation of this clinic (Pham et al. 2016) was found to
reduce the frequency of unnecessary admissions for and cancellations of surgery but
there was significant uncertainty around the effect of the clinic on clinical outcomes
and costs. The evaluation suggested that there may be additional unmeasured
factors to the identified modifiable medical co-morbidities that contribute to patient
complexity (Pham et al. 2014), thus influencing referral to the clinic and patient
outcomes.
This explanatory study was designed to provide an in-depth examination of the
surgeons’ perceptions of referral practices to the clinic and thereby illuminate the
findings of the clinic evaluation. Factors related to the referral of patients for med-
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ical optimization identified by the surgeons but not captured by the available data
would indicate the potential presence of unmeasured confounding in the clinic eval-
uation. Additionally, the surgeons’ perceptions of the clinic would inform whether
the value of the clinic was appropriately captured in the outcomes used in the clinic
evaluation. The aims of this study were to understand the factors that influence a
surgeon’s decision to refer a patient to the clinic, and how the clinic impacts on the
management of complex patients.
7.3.3 Methods
Research design
This explanatory sequential study design (Klassen et al. 2012) was part of a lar-
ger mixed methods study evaluating the assessment and management of high-risk
patients provided by an outpatient Perioperative High Risk Clinic (“the clinic”).
The qualitative data collected was used to explain and build on the findings of the
quantitative evaluation of the services provided by the clinic.
Taking a realist epistemological approach, theoretical thematic analysis was used
to analyze the collected data (Braun and Clarke 2006). There was a focus on themes
to help explain the complexity of the patient population referred to the clinic and
provide insight into the context, subjective attitudes and behaviors that govern the
surgeons’ decision making processes in assessing and managing complex surgical
patients.
Setting and participants
Semi-structured interviews were conducted in person with surgical consultants from
five specialties at the Royal Adelaide Hospital and The Queen Elizabeth Hospital,
Adelaide, South Australia. Participants were recruited with an invitation letter via
post or electronic mail and followed up with a telephone call. Surgical consultants
who were eligible to refer patients to the clinic were invited to participate in the
interests of obtaining a range of perspectives on the clinic. Sampling was purposive
with the aim of achieving data saturation.
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Data collection
The interviews were conducted by one of the authors (CP), a researcher with no clin-
ical relationship with patients or staff of the clinic but who had recently completed
the quantitative evaluation of the clinic, between March and July 2014. One-to-one
interviews were held in either the surgical consultant’s private office or a quiet of-
fice/room in the hospital ward. Prior to being interviewed, participants received an
information sheet and completed a consent form.
The study team developed an interview guide and compiled interview and prob-
ing questions focusing on the reasons for and expectations of referral to the clinic,
and the level of involvement of the clinic in the surgical decision making process and
the delivery of clinical care to patients. The questions and prompts in the guide
were developed by the project investigators (academic researchers, the clinic phys-
ician and a surgeon) and piloted on selected surgeons to test the appropriateness
and flow of questions. For the interview guide, see Appendix 7.4.1.
All interviews were audio recorded and transcribed by either the interviewer,
or a professional transcription service and reviewed by the interviewer to ensure
accuracy.
Data analysis
Themes were identified at a semantic level focusing on the explicit, stated meaning
of the data (Braun and Clarke 2006). CP initially coded all transcripts and EH
reviewed and coded selected transcripts. CP and EH examined the consistency of the
coded text and explored and refined the emerging themes. All authors contributed
to the final selection of themes and their interpretation in relation to the overall
research questions.
NVivo 10 for Windows (QSR International Pty Ltd.) was used to transcribe,
code and manage data.
Ethics approval to conduct the study was granted by the South Australian
Department of Health Human Research Ethics Committee (HREC Protocol No.
490/01/2015) and the Royal Adelaide Hospital Research Ethics Committee (RAH
Approval No. 120225/120225a). Written informed consent was obtained from each
participant, including permission to audio-record the interviews and use anonymized




Of the 27 invitations sent, 7 surgical consultants agreed to participate (one of whom
referred patients infrequently to the clinic). The reasons for non-participation were
not known. The duration of the interviews ranged from 10 to 34 minutes (mean 23
minutes). Interviewees were predominantly male, with surgical experience ranging
from 11 to 31 years, indicating that all had quite extensive experience on which
to draw upon in the interview. The surgical specialties included vascular surgery;
colorectal surgery; orthopedic surgery; ear, nose and throat surgery; and general
and hepatobiliary surgery. For participants who frequently referred patients to the
clinic, data saturation of themes was achieved.
Two main themes were readily identified and explored in this analysis: factors
that influence a surgeon’s decision to refer a patient to the clinic, and the role of
the clinic in assessing and managing complex patients.
Theme 1:
Factors that influence a surgeon’s decision to refer a patient to the clinic
In discussing how they assessed and determined whether a patient should be referred
to the clinic, participants generally identified at least two of the following factors. All
participants initially described the optimization of co-morbidities and would then
elaborate with discussion of exemplar patient cases to demonstrate the challenges
with managing complex patients and communicating the risks involved with having
surgery.
(a) Optimization of co-morbidities
All participants, including the participant who referred patients infrequently, men-
tioned the optimization of co-morbidities as one of their main expectations when
referring a complex patient to the clinic and felt that it complemented the care they
provided.
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“I see the role of it as identification of patients who have a higher risk
of morbidity and mortality related to the [. . . ] surgical treatment of
their disease, which are largely cancer diseases, and after identification
of their risk, then to optimize their care to reduce that risk to the
lowest possible level for surgery.”
(Participant 3)
And
“ . . . their medical issues are examined or delineated and any further
investigation that might be warranted is undertaken, medications may
be changed [. . . ] and in the process, though I see the optimization prob-
ably more as the role, it gives the patient further insight into what
sort of medical risks are involved and potential implications. So it
adds to the informed decision making process for consent.”
(Participant 2)
And
“I expect probably a more thorough assessment from a medical dis-
ease point of view, an optimization of their conditions whether it’s an
adjustment of their inhalers or their cardiac medications or whatever.
Some more streamlined advice on what they should be doing with
their medications in the perioperative period.”
(Participant 5)
The assessment and review of current medical conditions and medication manage-
ment in complex patients appears to be the main reason for referral to the clinic.
The focus on the impact of such medical conditions on surgical risk was seen to add
to the decision making process and to improve patient informed consent.
(b) Management of factors other than co-morbidities
Beyond the checklist of potentially modifiable co-morbidities that can be optim-
ized by the clinic, there appeared to be unmeasured factors that contributed to the
surgeon’s decision to refer, such as a patient’s physiological reserve and resilience.
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When discussing the decision to refer a complex patient to the clinic, all parti-
cipants referred to clinical experience and judgment in discussing how they assessed
increased risks and uncertainty during and after surgery.
“ . . . we don’t use an algorithm to decide, it’s just an experiential thing
and so I think of patients as oh my goodness they’re going to be quite
difficult to look after afterwards, I think we should get some help be-
forehand. You just look at them and go you’re going to break if I touch
you. It’s a resilience thing in a way. We talk about psychology but it’s
a physical resilience to see how much reserve do you think they’re
going to have. Therefore if it’s very low then you need to make sure




“I think it’s identifying patients that have a low reserve so while
they might not have identifiable medical problems you recognise that
they are patients that potentially don’t do well after the operation and
I suppose that we accept that any major surgery takes someone down a
level of functioning so if someone’s only just functioning that’s going to
be significant. I suppose with fragility, we look at how they cope with
everyday function as a sort of measure of how robust they are.”
(Participant 2)
And
“So just going to the waiting room, walking them in, sitting them
down, getting them up onto the bed. I mean if it’s hard work to
get them up onto the bed, you need to crow bar them onto the bed or
whatever, a bit of a red flag will go up. How far they can walk or




“You get a pretty good idea of frailty in the first 90 seconds when
they walk into the room, really. It’s just sort of clinical acumen, I
suppose. That probably sounds a bit snobby. But you can just tell -
if you sat on a bus and looked at the old people on the bus, you’d
think, well, she looks pretty good for 70 and the man looks like he
needs help to sit down or to stand up.”
(Participant 6)
As the previous quotes highlight, there was variance in how participants discussed
their use of clinical experience and judgement; however, these assessments commonly
focused on the physical dimensions of reserve and fragility. One participant described
the combination of physical and cognitive characteristics that could also prompt a
referral to the clinic, suggesting informal checks for indicators of frailty.
“Strength of handshake, mobility, cognitive ability at answering
questions, focusing properly, how they interact with their family.
All those things I think all add up to bizarrely an increased operative
risk which we somehow try and translate into needing to see a specialist
about that beforehand.”
(Participant 4)
There appears to be a stronger focus on the patient’s physical characteristics by
observing their ability to perform usual activities than the cognitive and psychosocial
functioning, but difficulties with both the physical and cognitive aspects were seen
to increase the operative risk.
Despite participants commonly describing the informal checks for some of the
indicators of frailty, none identified the use of a quantitative measure.
(c) A strategy for managing difficult and complex cases
Given the complexity of the patient and the uncertainty regarding surgical risk,
some participants viewed the clinic as a means to provide an independent, second
opinion on whether the patient should proceed with surgery.
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“But as I say, having that second set of eyes or third-party assessment
[. . . ] because it’s very difficult where a patient’s come along with an
expectation that they need something done. They generally expect
that we’re going to see them and say, right, well, yes, away we go. If
you try to tell them that maybe, really, it’s not the best thing
to do, I think it’s very useful to have a third party who’s clearly
disconnected from the surgical clinic and say, look, you’re actually
not - do you really want to do this? Do you realise this is a bit risky?”
(Participant 6)
And
“ . . . I mean probably the most common reason I use the clinic is for
the patients to understand the risk involved in surgery. So patients
I don’t particularly want to operate on, for me that’s the ideal situation.
The patient says why can’t you do this [. . . ] why is it risky? So they go
and see [the clinic physician] and then [the clinic physician] tells them.
It helps put the thing in perspective for them.”
(Participant 7)
These examples highlight how the referral for a second opinion not only provides
an additional clinical assessment but also a strategy to manage the expectations of
patients, particularly in communicating the risks with surgery.
(d) Holistic assessment and care of the patient
Referral to the clinic is currently ad hoc and largely at the discretion of the sur-
geon. Prior to the establishment of the clinic, surgeons would refer patients to
sub-specialists, such as the cardiologist and nephrologist. One participant in this
study continued with this practice and very rarely referred patients to the clinic.
“. . . I’ve been around for a long time and used to operating on high-
risk patients without having someone review them, so we’ve got a
pretty good understanding of what risks are involved. A pretty good
understanding of who needs to have something done [. . . ] Often if pa-
tients need an operation then there’s not much that the high-risk
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clinic can do. I mean if things are - medical conditions are not
treated optimally then that’s a role for the high-risk clinic. I don’t
really need a high-risk clinic to tell me this patient might have an in-
farct, they might have a stroke when I’m doing an operation, to prevent
it [. . . ] They’ve by and large seen other people. Other people manage
those things, if everything seems to be controlled. If you can’t correct
something then they either have to have the operation or they don’t.”
(Participant 7)
This participant distinguished the surgical from the medical and perceived the clinic
to have a role in reviewing medical conditions that were not well managed, but this
participant did not require this additional clinic review to supplement their surgical
practice. In contrast, those who referred patients to the clinic frequently viewed it
as a means to provide a snapshot of the overall health of a patient with multiple
medical co-morbidities, as opposed to stand-alone reports from other sub-specialists.
“. . . these patients, they’ve usually been cigarette smokers or possibly
alcoholics as well, and so related to their lifestyle choices they often have
co-morbidity issues related to that, such as issues of cardiac/pulmonary
disease sometimes renal disease, diabetes and when people have more
than one area of problem, this is when the problem occurs. The time to
get patients in to see each individual clinic, getting a report from
each clinic, and trying to coalesce the importance of each of these
co-morbidities into one single answer is really what the problem
was. So we see the benefit of the high-risk clinic as the coalescence




“. . . it’s also a bit more holistic so rather than looking at each indi-
vidual medical problem that a specialist might see someone for,
we’ve got someone who integrates the whole thing, which is very
beneficial.”
(Participant 2)
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And
“. . . the high-risk clinic is able to access the various bits of information or
plug these people into clinics to get extra bits done that we can’t. Before
this clinic started, if I saw someone who had a cardiac history, I’d
say to them, well, we can do your operation but you have to go and
see the cardiologist first. So then they’d go and they’d sit in the queue
for the cardiac clinic, which might be forever. Or they’d see the registrar
who’d never seen them before and things - and it’d just - so this really
pulls together all the bits.”
(Participant 6)
And
“I think a lot of specialists just compartmentalize - I’ll worry about
the heart and the respiratory guy will just worry about the lungs
and you’ll see that quite a lot that no-one puts it all together. So I
think that’s important –. It’s an integration of all the different disease
processes going on.”
(Participant 1)
The holistic assessment of the patient provided by the clinic was described by
many participants as a consolidation of all the relevant patient factors that sup-
port their clinical decision making processes and streamlines patient care, a service
not provided elsewhere. It was thought that the medically-focused role of the clinic
physician complemented their role allowing them to focus on the surgery. How-
ever, this perceived value was not held by all participants, which may explain the
continued ad hoc nature of patient referrals to the clinic.
Theme 2:
The role of the clinic in assessing and managing complex patients
When discussing the role of the clinic, two related sub-themes were dominant and
focused on the management of risk in complex patients. The participants emphas-
ized the risks for both patients and surgeons and that the involvement of the clinic in
the decision making process and communication of risks, particularly in predicting
how the patient would cope post-surgery, was valued by surgeons.
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(a) Informing and assuring the patient
The clinic provided additional detail on the risks to the patient and the potential
implications of surgery, and was perceived to be beneficial to patients who were
concerned and hesitant about having surgery.
“It’s useful for us but I think it’s also useful for the patient, knowing
what’s expected, how they’re going to be managed postoperatively
to try and minimise their risk of pneumonia, etc. [. . . ] I see the
optimization probably more as the role, it gives the patient further
insight into what sort of medical risks are involved and potential
implications. So it adds to the informed decision making process for
consent.”
(Participant 2)
It also appeared to be beneficial for patients who were adamant about undergoing
surgery despite having a high risk of morbidity and mortality.
“I think for those that need it, a more clear indication of risk that
they’re putting themselves at. We can only tell them so much about
the complications of hip replacement, but if they’ve got other ill-
nesses their risk of mortality and other perioperative morbidities I
think it would be important to be assessed as well.”
(Participant 5)
The above example also describes the separation of roles with the surgeon discuss-
ing the potential complications of the surgical procedure and the clinic physician
providing supplementary information on the potential complications as a result of
the patient’s medical conditions. This reinforces the focus on adding to the decision
making process and informed patient consent and appeared to provide a form of
assurance for the patient.
“Now the way that I’d probably view it most importantly though is that
from the patient’s point of view, they are often worried and scared,
they view their outcome as being uncertain [. . . ] they’re worried
that they’re going to die, not from the cancer but from the impact of
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having an operation [. . . ] If [the clinic physician] says to the patient,
“I think that you are fit to go through this type of procedure”,
they feel confident about that. Patients often have a traumatic time
psychologically, going through management of cancer, the diagnosis and
treatment of it, but [if] everybody that’s around them that works in that
team [is confident], they feel happier with that.”
(Participant 3)
(b) Assuring the surgeon
Descriptions of the relationship between the surgical team and the clinic revealed
that there was ongoing communication and involvement in the management of the
patient between the two parties throughout the surgical period, and not just a one-
off consultation. This appeared to provide a form of assurance for the surgeon and
the surgical team.
“I think communication between the high-risk clinic staff and the re-
ferring surgeon is important because there can be discussion about
how important a procedure is relatively to treating the patient con-
servatively [. . . ] Often [the clinic physician will] ring me up and say,
“can we wait 3 or 4 weeks, I’ll get these tests done and I’ll start a meeting,
[. . . ] is it safe to do that?” Usually there’s quite good communication.”
(Participant 1)
And
“I find it useful when [the clinic physician] rings me to say that this
is a real issue or there’s a patient that is a bit outside the norm or
their risk is going to be unacceptably high that that personal contact




“I think it’s useful for everyone who’s involved because if there’s some
concern on the day that they come into theatre, the anesthetist will say,
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well, yes, he’s been to the high-risk clinic, he’s a bit crumbly, but
they seem to have sorted it. I think it gives the anesthetist a bit more
reassurance as well.”
(Participant 6)
For some specialties, the clinic physician was seen as a member of the surgical
team and one who had expertise to medically manage the patient in preparation for
surgery.
“[the clinic physician is] an embedded part of our unit, which is
critical. [. . . ] it’s not just a referral to a clinic but it’s an embedding
of a physician within the unit who gives us expert opinion on those
areas [. . . ] [the clinic physician] probably has more expertise than any
other physician in the hospital who doesn’t see our patients regularly.
[the clinic physician is] a specialist physician for surgeons. [the clinic
physician] knows more about surgery than most physicians.”
(Participant 3)
And
“[the clinic physician] comes to our radiology meetings so [the clinic
physician is] part of the unit [. . . ] often if I talk to [the clinic physician]
I say, “well ideally we should an open because the anatomy’s not favour-
able but if they’re really high-risk we may change to doing endoluminal
even though the long-term results aren’t as good”. I think it’s useful
to have that discussion in complicated cases or cases which are cer-
tainly not that straight forward. And it goes both ways, us letting
[the clinic physician] know what the scoop is and [the clinic physician]
maybe saying, “you need this, this and this and you can have an open””
(Participant 1)
The clinic was perceived to be beneficial for both the patient and surgeon and
helped in determining the most appropriate treatment pathway, especially for com-
plex cases.
122 CHAPTER 7. EVALUATION VALIDITY
(c) Supporting postoperative management
Management of the patient also extended to the postoperative period, with the
clinic physician providing recommendations for postoperative care of the patient and
the perioperative involvement of clinic nurses (as part of the clinic team) ensuring
consistency of care and appropriate postoperative follow-up.
“[the clinic’s] role to me now is optimizing patient care and time of
surgery with preoperative care but also perioperative care with the
perioperative physician team. So I think it’s only fair to get people
involved in looking after people postoperatively only if they’ve had a role
in preoperatively.”
(Participant 4)
The postoperative management provided by the clinic physician and team not only
focuses on the potential medical complications after surgery but extends to managing
the patient’s expectations regarding care and assistance after they are discharged
from hospital, as described in the following quote:
“I guess there’s two things, one is if there is an intervention required for
example they need a coronary stent or something like that, then that’s
kind of a no-brainer, but if there are issues that maybe require con-
valescence afterwards, high risk of confusion afterwards, those sorts
of things that’s useful advice but you have to take into account that
that doesn’t usually affect necessarily decision making for the procedure.
But there are a reasonable number of patients that are just coping at
home and if they do have a major procedure then they’ll probably never
get home again and that’s important because a lot of patients want
their independence and have no concept that a major intervention
may end up with them going to a care facility on a permanent basis
not just for some convalescence.”
(Participant 1)
All participants acknowledged the importance of the clinic’s involvement in the
postoperative management of their patients. However, the clinic physician’s recom-
mendations for postoperative care were viewed to be for the benefit of the medical
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and nursing staff who were involved with the day-to-day care of the patient in the
postoperative period.
7.3.5 Discussion
This explanatory study aimed to assess the validity of findings from a recent evalu-
ation of an outpatient Perioperative High Risk Clinic that optimizes surgical patients
with a high risk of morbidity and mortality by targeting and managing their modi-
fiable medical co-morbidities (Pham et al. 2016). This study focused on identifying
factors that influence a surgeon’s decision to refer a patient to the clinic and the
impact of the clinic on the management of complex patients.
The validity of the evaluation findings
The recent evaluation of the clinic (Pham et al. 2016) controlled for potential con-
founding by using a range of patient-level factors that could potentially influence
whether a patient was referred to the clinic. Factors were limited by the routinely
collected data available and included patient demographics, surgery-related factors,
patient’s physical function (using proxy measures such as the ability to walk around
the house and upstairs) and the modifiable medical co-morbidities targeted for op-
timization by the clinic. The results varied depending on the method used to con-
trol for differences in observed potential confounders suggesting that the inclusion
of other unmeasured confounding factors would improve the characterization of the
complexity of patients referred to the clinic.
Findings from this study suggest a high likelihood of unmeasured confounding
in the quantitative evaluation of the clinic and additional relevant outcomes that
could be collected to describe the perceived value of the clinic. The presence of
potentially modifiable co-morbidities that increase the risk of morbidity and mor-
tality in patients was confirmed to be the initial indicator for a clinic referral for
optimization, thereby supporting the covariables used in the quantitative evaluation
to control for confounding. However, unmeasured factors such as the surgeon’s sub-
jective clinical assessment of the patient and the informal use of frailty indicators
also appeared to influence whether a patient was deemed to be complex and requir-
ing additional management and treatment. This is consistent with previous studies
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(Wijeysundera et al. 2012, Thilen et al. 2013) reporting that associations between
preoperative consultation and the presence of medical co-morbidities only explained
a small proportion of the substantial variation in referral patterns for consultation.
This small study provides further insight into other possible sources of variation in
such referral patterns.
Participants within this study described consideration of the patient’s physiolo-
gical reserve and resilience, indicated mainly by physical characteristics such as the
ability to walk from the waiting room to the consult room, strength of handshake,
and general physical function, as contributing factors to their decision to refer a
patient to the clinic. Cognitive and psychosocial functioning were considered but
were not the main focus for the participants. The clinic includes a mini-mental state
examination for cognitive impairment and the likelihood of postoperative delirium
as part of the medical assessment, which appears to complement this aspect of pa-
tient care for the participants. Frailty and quality of life measures, not routinely
collected in clinical data, could potentially enhance the quantitative evaluation by
improving the characterization of clinic patients. However, other aspects of the sur-
geon’s subjective assessment, such as clinical judgment, are difficult to quantify and
their influence on the reasons and thresholds for referral warrant consideration.
Clinical decision making is a complex process (Minick and Harvey 2003), depend-
ent on the surgeon’s clinical judgment in conjunction with evidence-based practice to
provide quality patient care (Pearson 2013, Newell et al. 1972) and the patient’s ana-
tomy, physiology and well-being (Crebbin et al. 2013). Clinical judgment has been
described to involve critical thinking, reflective practice, problem solving, judge-
ment, ethical values and professional accountability (Standing 2005). With the
accumulation of data from various clinical experiences, this judgment could be in-
terpreted as a cognitive process involving pattern recognition that draws upon the
interpretation of clinical evidence within the experience, understanding and prior
knowledge of the practitioner (Francis 2009) and differentiates the novice from the
expert practitioner (Benner and Tanner 1987). Unfortunately, there are no reliable
and validated measures of clinical judgment (Minick and Harvey 2003) but further
research could acknowledge that variation exists and focus on how thought processes
of the expert practitioner, such as the types of questions asked of the patient and
the forward reasoning, determine the most appropriate treatment pathway (Willi-
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ams 2017). This could inform and improve the shared decision making process and
provision of patient-centered care.
The perceived value of the clinic
Participants described additional value in the form of an overall assessment of the
current health status of a patient, and the benefits of an integrated approach re-
garding assurances to both the patient and the surgeon beyond the clinical outcomes
measured in the quantitative evaluation.
Clinical outcome data, such as surgical cancellations, length of hospital stay,
postoperative complications, mortality and quality of life, are important to demon-
strate the cost-effectiveness of preoperative medical consultations but the additional
perceived value of the clinic may not be adequately captured in such clinical out-
come measures (Pham et al. 2016). The reduction in uncertainty and the discussions
regarding risk and expectations post-surgery, elements of value evident in this study,
warrant consideration when assessing the value of health care interventions such as
the high-risk clinic. However, how to best measure and include such elements of
value and other patient-reported outcomes into cost-effectiveness analysis remains
a subject of debate (Lakdawalla et al. 2018).
The surgeon and clinic physician relationship has also not been well described
in previous studies (Pham et al. 2017), making it difficult to determine whether the
clinic physician provided a stand-alone consultation with no postoperative patient
follow-up or an integrated approach to patient care between the surgeon and clinic
physician. The clinic physician in this study was considered a member of the surgical
teams with expertise on the medical management of patients in preparation for sur-
gery. There was ongoing communication and active involvement in the management
of the patient between the surgeon and the clinic physician throughout the surgical
period. Participants valued the role of the clinic in providing additional information
and the opportunity for further discussion of the risks and potential implications
with surgery to help with the management of patient expectations after surgery.
Good communication has the potential to improve overall patient care coordination
and the patient experience (Rosenstein 2012).
In this study, we have explored the surgeon’s perspectives of the clinic as it is
the surgeon who authorizes the referral of a patient for preoperative assessment
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and management. The small sample of participants limits the generalizability of
the findings to other clinics providing a similar service. The lack of participation
by clinicians choosing not to use the clinic is also a limit to the study. The as-
surances provided to both the patient and the surgeon through the assessment and
management of risk and uncertainty regarding surgery should be explored through
further qualitative interviews or validated shared decision making questionnaires.
Additional perspectives from the patients, the clinic team and other medical pro-
fessionals collaborating with the clinic would also provide further insight into the
aspects of care that provide additional value.
Decisions to invest in services such as those provided by the clinic are driven
by their impact on the costs and health benefits. The development, validation and
evaluation of a checklist, based on the key factors identified through qualitative
and quantitative evaluations, could guide the assessment and selection of patients
who would benefit most from such services and enable a robust evaluation of the
clinic. Ensuring the optimal use of such services, as opposed to the ad hoc nature of
the current referral process, would improve the effectiveness of existing clinics and
inform the implementation of clinics at other hospitals.
Conclusions
The integration of the preoperative medical consultative service provided by the
clinic in this study appears to offer additional value in supporting the decision-
making process for the surgical team and patient beyond the clinical outcomes. The
factors that influence a surgeon’s decision to refer a patient to the clinic appear to
be driven by the aim to manage the uncertainty and risk to the patient regarding
surgery and it was seen as a strategy for managing difficult and complex cases.
The current ad hoc nature of determining which patient to refer to the clinic, as
described by the participants in this study, may explain the variations in the clinical
outcome measures from the quantitative evaluation, and suggest a high likelihood of
unmeasured confounding, with frailty and quality of life measures not captured in
current routinely collected hospital data. Further research is required to explore
the perspectives of the patient, the clinic team and other medical professionals
collaborating with the clinic and guide the optimal use of the preoperative medical
consultative service. This will inform improvements to the design, implementation
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and evaluation of preoperative medical assessment and management.
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7.4 Appendices
7.4.1 Appendix 1. Interview guide
Preoperative medical assessment and management
 Provide information sheet
 Obtain informed consent (2 copies)
• Confidentiality - all data de-identified
• Permission to audio record this discussion
• Please feel free to ask any questions during the interview
 Ask whether the participant would like to be sent a transcript of the interview
for them to check and make further comments if necessary
The focus of this discussion will be on the perioperative high-risk clinic at the RAH.
Findings from our quantitative analyses on the impact of the clinic on certain out-
comes (LoS, mortality, and complications) are not what we expected.
We thought surgeons would be the best people to speak with as you have the ex-
pertise to help us explore what we might be missing from our analyses.
We would like to explore your perspectives of the clinic and give you the opportunity




Start time: AM / PM
End time: AM / PM








 What is your current position at the RAH/TQEH?
 What year were you awarded FRACS?
 How long have you been working at the RAH/TQEH?
 How many other consultants are there currently in your specialty?
B. THE PREOPERATIVE HIGH RISK CLINIC
This interview focuses on patients scheduled for elective surgery and the process
from GP referral to admission for surgery, and the involvement of the periop-
erative high-risk clinic in the management of complex patients with multiple
medical co-morbidities.
 Q1. Could you please describe your understanding of the role of
the high-risk clinic?
Probing questions:
• Do you know about the physician-led preoperative high-risk clinic?
• How did you first hear about it?
• Do you refer patients to the clinic?
If yes, how often? How many patients per week on average?
If no, skip to section F-G
• What prompted you to begin referring?
 Q2. Do you think the clinic complements what you do?
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 Q3. When you refer patients to the high-risk clinic, what do you
expect to be done?
Probing questions:
• Is it more about risk management or benefit to the patient?
• What impact do you think the medical consult has? Reduce the like-
lihood of having peri- and post-operative complications? Long-term
benefits post-discharge?
C. DECIDING REFERRAL
 Q4. How do you determine whether the patient should see a
physician or other specialist?
Probing questions:
• Is it about the availability of specialists? Or when there are multiple
issues and not sure which condition needs attention?
• Before the clinic was established, who did you refer to for medical
optimisation?
D. DETERMINING ELIGIBLE PATIENTS
 Q5. Over the last 12 months, what would be your main reason
for referring a patient to the high-risk clinic?
 Q6. What are the key factors you use to determine whether a
patient should be referred to the high-risk clinic?
Probing questions:
• Do you use specific clinical measures?
• How about cognitive and psychosocial factors?
• Preliminary analysis of quality of life data suggests that self-care and
usual activities are predictive factors for clinic referral. Do you think
this might be a useful in your decision making?
E. MEDICAL CONSULT
 Q7. The clinic provides a list of recommendations, how do you
deal with them?
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Probing questions:
• Do you find them useful? If no, how could they be improved?
• There can be numerous recommendations for some patients, in these
instances how do you prioritise?
• If you focus on surgical recommendations only, what happens to the
other recommendations?
• When you check on the patient postoperatively, do you refer back to
these recommendations?
F. DISTRIBUTION/COMMUNICATION OF REFERRAL GUIDELINE
 Q8. Have you seen this referral guideline? (see Chapter 7.4.2)
Probing questions:
• Do you think it is useful/helpful? Why or why not?
• Do you think the communication could be improved? How? Dissem-
ination?
G. LOW/NO REFERRAL FOR PREOPERATIVE MEDICAL CONSULTATION
 Q2. May I ask why you do not refer?
Probing questions:
• Could you explain why you think it’s not useful/effective?
• Do you think it does not address a particular need?
 Q3. What do you do instead? How do you manage complex
patients with multiple co-morbidities?
Probing questions:
• How do you prioritise management of co-morbidities?
• How do you manage the complexities of these needs?
• What do you think might address the needs of these complex patients
better?
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7.4.2 Appendix 2. Referral guidelines
Guidelines for referral to the physician-led Perioperative High Risk Clinic
The Perioperative High Risk Clinic (POHR) provides physician-led assessment of
patients being worked up towards elective surgery. The assessment aims to diagnose
and optimise medical conditions which may impact on the surgical outcome of these
patients. This will include liaison with the General Practitioner to try and improve
longer term medical care, and advice to interns to guide appropriate postoperative
medical management, and may include advice on risk: benefit of proceeding with
the planned surgical procedure.
Patients seen in the POHR will be supported after surgery by the perioperative
clinical practice consultant.
Any patient that is felt to be likely to benefit from preoperative physician-led as-
sessment will be seen in the POHR clinic.
All referrals will be triaged according to surgical priority (i.e. patients awaiting
curative surgery for malignancy will be prioritised over patients awaiting non-life
saving elective surgery).
Referrals will be accepted from any and all medical practitioners.
Medical co-morbidities that may be targets for optimisation prior to elective surgery
include:
CARDIAC
Symptomatic angina or cardiac failure
Previous cardiac history with no recent cardiac follow up
Hypertension
History of CVA, MI or CCF
Advice regarding antiplatelet agents
Previous drug eluting stent insertion
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PULMONARY




Any degree of renal dysfunction may be associated with increased risk of
perioperative morbidity and mortality
THROMBOEMBOLIC
Advice regarding anticoagulation particularly warfarin
DIABETES
Poorly controlled diabetes
Significant diabetic end organ damage
ANAEMIA
For further information or to discuss potential referrals please contact either:
Dr Katy Gibb ext 22074







The aims of this research were to evaluate the preoperative assessment and man-
agement services provided by the physician-led high-risk clinic, and provide recom-
mendations for improvement. It is anticipated that the findings from this evaluation
will guide the identification of elective surgical patients who would benefit most from
preoperative physician-led medical optimisation, and provide clarity on the collabor-
ative care provided by the high-risk clinic and surgical teams in managing complex
patients. The principal findings, contributions and recommendations for further
research are presented in this concluding chapter.
8.1 Principal findings
The clinical rationale
A set of potentially modifiable co-morbidities in elective surgical patients are associ-
ated with increased length of hospital stay and postoperative complications (Chapter
3). The nine potentially modifiable co-morbidities identified include ischaemic heart
disease, congestive heart failure, stroke, diabetes mellitus, renal impairment, an-
aemia, dementia including Alzheimer’s disease, asthma or COPD and primary hy-
pertension. This supports the clinical rationale of the clinic in that outcomes will be
worse in the subset of patients for whom such co-morbidities are poorly controlled,
and that timely intervention to improve control in the period prior to surgery will
improve postoperative outcomes.
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A review of the literature
A systematic review of the literature found that the effectiveness of preoperative
medical consultation is uncertain due to a lack of high-level comparative evidence
(Chapter 4). The design and implementation of preoperative assessment applied to
date was heterogeneous, with minimal detail from each of the included studies on
the actual services provided as part of the intervention. However, the consolidation
of existing evidence identified potential elements of preoperative assessment that
may contribute to better outcomes, such as the eligibility criteria for referral, and
the timing and process of assessment.
The evaluation of the costs and outcomes
An evaluation of the costs and effects of a local outpatient clinic providing physician-
led preoperative assessment and management was conducted using a propensity
score-based approach with retrospective and prospective data (Chapter 5). The
clinic was found to reduce the frequency of unnecessary admissions and cancella-
tions, but significant uncertainty remained around the effect of the clinic on length
of hospital stay, postoperative complications, hospital costs and post-discharge mor-
tality. Supplemental data on a prospective cohort of patients identified preoperative
health-related quality of life as a potential unmeasured confounder in the evaluation.
The lower mean preoperative QoL index score reported in clinic patients suggested
that preoperative QoL could improve the characterisation of clinic patients (Chapter
6). This evaluation illustrates the value of mixed retrospective prospective obser-
vational study designs but also highlights the need to prospectively plan for the
evaluation of costs and effects alongside the implementation of significant service
innovations.
Validating the evaluation findings
Semi-structured interviews with surgeons found that the factors influencing their
decision to refer a patient to the high-risk clinic appear to be driven by the aim to
manage the uncertainty and risk to the patient regarding surgery and it was seen
as a strategy for managing difficult and complex cases (Chapter 7). The current
ad hoc nature of determining which patient to refer to the clinic may explain the
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variations in the clinical outcome measures from the quantitative evaluation, and
suggest a high likelihood of unmeasured confounding, with the surgeon’s subjective
clinical assessment of the patient, frailty and quality of life measures not captured
in current routinely collected hospital data. Further, the integration of the services
provided by the clinic in this study appear to offer additional value in supporting
the surgical decision making process for the surgical team and patient beyond the
clinical outcomes, such as managing the patient’s expectations regarding care and
assistance after discharge from hospital. Additional perspectives from patients, the
clinic team and other medical professionals collaborating with the clinic should be
explored and would provide further insight into the aspects of care that provide
additional value.
8.2 Contributions to public health and medicine
This research represents the first comprehensive evaluation of services for the preop-
erative assessment and management of high-risk surgical patients. This evaluation
suggests that preoperative intervention may be cost-effective in selected patients,
and the identification of key preoperative indicators that influence postoperative
outcomes may better inform shared decision-making around the risks and bene-
fits of elective surgery. In the quantitative evaluation, propensity-based matching
reduced the differences in the postoperative outcomes between clinic and control pa-
tients and, in some cases, improved outcomes in favour of the clinic. This suggests
that there is a subset of patients who have a greater capacity to benefit from the
services provided by the clinic. The inclusion of clinic patients with a lower capacity
to benefit, due to the ad hoc nature of referral to the clinic, may have diluted the
effectiveness of the clinic. Alternatively, the control patients may have had a lower
risk of poor postoperative outcomes due to unmeasured confounding.
The involvement of the clinic in the communication of risks to the patient, par-
ticularly in predicting how the patient would cope post-surgery, was valued by the
surgeons. This appeared to provide additional support to both the patient and the
surgeon and contributed to the decision making process. Moreover, the surgeon and
clinic physician relationship and the collaborative care provided has been described
in detail, an area not well described previously. Documenting the collaborative
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nature of the care provided in this setting enabled the identification of additional
elements of value and an understanding of the challenges with managing complex
patients. This would also enable future comparisons with similar clinics nationally
and internationally.
Methodologically, this research has illustrated the difficulties with retrospective
service evaluations involving complex patient populations. It has demonstrated the
value of the novel covariate balancing propensity score method to minimise observed
confounding, and of the prospective assessment of the likelihood of an unmeasured
confounder. As demonstrated in the quantitative evaluation, there are limitations
to the use of routinely collected data. Despite the benefits of immediate access to a
large, longitudinal dataset, some variables of interest were missing or not collected.
The prevalence of co-morbidities in the routinely collected data was underestimated
as the coding of data was based on the information in patient casenotes. Through the
data collection process in the quantitative evaluation, stroke, anaemia and demen-
tia were under-reported and required additional manual searching of the patient’s
medical history for previous hospital admissions, pathology results and hospital dis-
charge summaries. The level of severity for each co-morbidity was also difficult to
determine, even with supplementary information from pathology results and medic-
ations. The routine collection of patient-reported outcomes, such as health-related
quality of life, would have improved this evaluation and could inform evaluations of
other models of care.
As a result of the reported findings, changes in clinical practice have already been
implemented with primary hypertension now targeted for medical optimisation and
a frailty assessment (checking for five key criteria: unintentional weight loss, self-
reported exhaustion, grip strength, walking speed and physical activity) has been
included in the standard assessments conducted by the high-risk clinic.
8.3 Recommendations for future research
Further research is required to inform the value, and the optimal design and imple-
mentation of coordinated involvement of physicians and surgeons in the provision
of care for high-risk surgical patients. A standardised approach to perioperative
decision-making processes should be developed and evaluated with a clear protocol
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or guideline for the assessment and management of surgical patients.
Clearly, some form of randomised controlled trial is the preferred study design
for the evaluation of such interventions, but in the absence of resources and buy-in
to undertake an experimental study, sufficiently robust data will need to be collected
and analysed to overcome the limitations observed in this study. Further evaluation
could be expanded to include hospitals in which the preoperative clinic has not been
implemented in order to provide greater covariate balance between the intervention
and control groups. The need to collect prospective data precludes the use of a
conventional pretest/posttest study with a contemporaneous control study design
for this intervention, as the clinic is currently operational and only retrospective data
would be available for the pretest period. Focusing on the differences in outcomes for
the same surgical procedure and matching clinic and control patients at the study
hospital to a control hospital could inform an adapted pretest/posttest approach,
though the issue of small sample sizes remains a key challenge.
Findings from the quantitative evaluation of the clinic highlighted an area of
further interest regarding mortality. There was a high proportion of deaths at 12
months in patients undergoing a TURP procedure compared with the other more
invasive procedures included in the analysis. This was an unexpected finding for
a procedure that is meant to improve quality of life, not life expectancy. Further
investigation ruled out prostate cancer as the cause of death, and suggests that
this could potentially be due to a higher proportion of unwell patients undergoing
the procedure. In contrast, the low proportion of deaths in patients undergoing
a TKR may be due to the procedure only being offered as an option if the pa-
tient is considered fit for surgery. Identifying the preoperative patient and clinical
factors associated with an increased risk of death within 12 months as well as other
patient-reported outcomes (e.g. functional decline and discharge institutionalisa-
tion after surgery) could be advantageous. This has the potential to enhance the
shared decision-making process and improve informed patient consent for surgery
or alternative treatment options in patients where risks outweigh benefits. This is
particularly relevant for cancer patients who may have to choose between surgery
(with a chance of prolonged survival but increased risks of adverse postoperative
outcomes and poor quality of life) and palliative care (certain death but quality of
life is maintained).
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The perceived benefits to both the patient and the surgeon through the assess-
ment and management of risk and uncertainty regarding surgery should be explored
through further qualitative interviews or validated shared decision making question-
naires. Additional perspectives from the patients, the clinic team and other medical
professionals collaborating with the clinic would also provide further insight into the
aspects of care that provide additional value.
8.4 Concluding remarks
An increasing ageing population will affect the demand and provision of hospital
services and the presence of co-morbidities adds to the complexity of patient care.
High-risk clinics were established in two large metropolitan public hospitals in South
Australia to optimise medical co-morbidities in patients in preparation for elective
surgery and coordinate postoperative care. Currently, there are no clear recom-
mendations regarding the selection of surgical patients for medical consultation.
Substantial practice variation exists with the decision to refer a patient at the dis-
cretion of the treating surgeon and influenced by the surgeon’s individual preference
for the intervention and subjective assessment of the patient’s need for medical as-
sessment.
However, in a resource constrained health care system, it is necessary to provide
evidence on costs and benefits to support funding decisions for new services. More-
over, the decision to fund preoperative optimization is not a single, binary decision
to fund or not to fund. There are also decisions around the capacity and scope of
the service. Given that the capacity is likely to be insufficient to cover all surgical
patients with potentially modifiable co-morbidities, there is a need to determine the
prioritisation of patients and to develop a systematic and evidence-based process
to guide referral of elective surgical patients for preoperative physician-led medical
optimisation. The development, validation and evaluation of a checklist, based on
the key factors identified through qualitative and quantitative evaluations in this
thesis and future research, could guide in the assessment and selection of patients
who would benefit most from such services. Ensuring the optimal use of such ser-
vices, as opposed to the ad hoc nature of the current referral process, would improve
the effectiveness of existing clinics and inform the implementation of clinics at other
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hospitals.
This evaluation provides a guide to the identification of elective surgical patients
who are likely to benefit most from preoperative physician-led medical optimisation.
It also provides clarity on the collaborative care provided by the high-risk clinic
and surgical teams in managing complex patients to inform the assessment of such
clinics in Australia. This research has demonstrated the need to plan for the robust
evaluation of new health service initiatives, which may be facilitated through better
co-ordinated planning and evaluation across Australian hospitals.
“Medicine is a science of uncertainty and an art of probability.”
– William Osler, 1965

